unix.py:120 DEBUG:/etc/localtime found
unix.py:136 DEBUG:1 found:
 {'/etc/localtime is a symlink to': 'America/Los_Angeles'}
database_session_service.py:441 INFO:Local timezone: America/Los_Angeles
plugin_manager.py:96 INFO:Plugin 'logging_plugin' registered.
plugin_manager.py:96 INFO:Plugin 'reflect_retry_tool_plugin' registered.
selector_events.py:64 DEBUG:Using selector: KqueueSelector
google_llm.py:133 INFO:Sending out request, model: gemini-2.5-flash-lite, backend: GoogleLLMVariant.GEMINI_API, stream: False
google_llm.py:139 DEBUG:
LLM Request:
-----------------------------------------------------------
System Instruction:
 You are an expert research assistant writing reports for the general public.
     
    For research requests: 
    1. Use `pubmed_search_agent` to find relevant research papers.  
    2. Use `summarize_agent` to summarize the papers found.
    3. Write a concise report. Your report MUST include the PMIDs returned from `pubmed_search_agent`.
    4. Always use the tools provided; never fabricate information or citations.
    

You are an agent. Your internal name is "research_paper_finder_agent".
-----------------------------------------------------------
Config:
{'tools': [{}]}
-----------------------------------------------------------
Contents:
{"parts":[{"text":"I want to know more about Gynecomastia Surgery."}],"role":"user"}
-----------------------------------------------------------
Functions:
pubmed_search_agent: {'request': {'type': <Type.STRING: 'STRING'>}} 
summarize_agent: {'request': {'type': <Type.STRING: 'STRING'>}} 
-----------------------------------------------------------

_trace.py:87 DEBUG:connect_tcp.started host='generativelanguage.googleapis.com' port=443 local_address=None timeout=None socket_options=None
_trace.py:87 DEBUG:connect_tcp.complete return_value=<httpcore._backends.anyio.AnyIOStream object at 0x112fac7a0>
_trace.py:87 DEBUG:start_tls.started ssl_context=<ssl.SSLContext object at 0x112ef6850> server_hostname='generativelanguage.googleapis.com' timeout=None
_trace.py:87 DEBUG:start_tls.complete return_value=<httpcore._backends.anyio.AnyIOStream object at 0x112e416a0>
_trace.py:87 DEBUG:send_request_headers.started request=<Request [b'POST']>
_trace.py:87 DEBUG:send_request_headers.complete
_trace.py:87 DEBUG:send_request_body.started request=<Request [b'POST']>
_trace.py:87 DEBUG:send_request_body.complete
_trace.py:87 DEBUG:receive_response_headers.started request=<Request [b'POST']>
_trace.py:87 DEBUG:receive_response_headers.complete return_value=(b'HTTP/1.1', 200, b'OK', [(b'Content-Type', b'application/json; charset=UTF-8'), (b'Vary', b'Origin'), (b'Vary', b'X-Origin'), (b'Vary', b'Referer'), (b'Content-Encoding', b'gzip'), (b'Date', b'Mon, 01 Dec 2025 05:58:05 GMT'), (b'Server', b'scaffolding on HTTPServer2'), (b'X-XSS-Protection', b'0'), (b'X-Frame-Options', b'SAMEORIGIN'), (b'X-Content-Type-Options', b'nosniff'), (b'Server-Timing', b'gfet4t7; dur=444'), (b'Alt-Svc', b'h3=":443"; ma=2592000,h3-29=":443"; ma=2592000'), (b'Transfer-Encoding', b'chunked')])
_client.py:1740 INFO:HTTP Request: POST https://generativelanguage.googleapis.com/v1beta/models/gemini-2.5-flash-lite:generateContent "HTTP/1.1 200 OK"
_trace.py:87 DEBUG:receive_response_body.started request=<Request [b'POST']>
_trace.py:87 DEBUG:receive_response_body.complete
_trace.py:87 DEBUG:response_closed.started
_trace.py:87 DEBUG:response_closed.complete
google_llm.py:186 INFO:Response received from the model.
types.py:6573 WARNING:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.
google_llm.py:187 DEBUG:
LLM Response:
-----------------------------------------------------------
Text:
None
-----------------------------------------------------------
Function calls:
name: pubmed_search_agent, args: {'request': 'Gynecomastia Surgery'}
-----------------------------------------------------------
Raw response:
{"sdk_http_response":{"headers":{"content-type":"application/json; charset=UTF-8","vary":"Origin, X-Origin, Referer","content-encoding":"gzip","date":"Mon, 01 Dec 2025 05:58:05 GMT","server":"scaffolding on HTTPServer2","x-xss-protection":"0","x-frame-options":"SAMEORIGIN","x-content-type-options":"nosniff","server-timing":"gfet4t7; dur=444","alt-svc":"h3=\":443\"; ma=2592000,h3-29=\":443\"; ma=2592000","transfer-encoding":"chunked"}},"candidates":[{"content":{"parts":[{"function_call":{"args":{"request":"Gynecomastia Surgery"},"name":"pubmed_search_agent"}}],"role":"model"},"finish_reason":"STOP","index":0}],"model_version":"gemini-2.5-flash-lite","response_id":"bS4taYH4D4DVjMcPyYKe-QY","usage_metadata":{"candidates_token_count":21,"prompt_token_count":210,"prompt_tokens_details":[{"modality":"TEXT","token_count":210}],"total_token_count":231}}
-----------------------------------------------------------

plugin_manager.py:96 INFO:Plugin 'logging_plugin' registered.
plugin_manager.py:96 INFO:Plugin 'reflect_retry_tool_plugin' registered.
google_llm.py:133 INFO:Sending out request, model: gemini-2.5-flash-lite, backend: GoogleLLMVariant.GEMINI_API, stream: False
google_llm.py:139 DEBUG:
LLM Request:
-----------------------------------------------------------
System Instruction:
Return a list of relevant research paper PMIDs based on the user's query. Focus on finding papers that directly address the user's topic. Focus on papers that are recent and highly cited. Return only the PMIDs in a comma-separated format.

You are an agent. Your internal name is "pubmed_search_agent". The description about you is "Searches for information using Pubmed".
-----------------------------------------------------------
Config:
{'tools': [{}]}
-----------------------------------------------------------
Contents:
{"parts":[{"text":"Gynecomastia Surgery"}],"role":"user"}
-----------------------------------------------------------
Functions:
get_dict_from_query: {'method': {'type': <Type.STRING: 'STRING'>}} 
-----------------------------------------------------------

_trace.py:87 DEBUG:connect_tcp.started host='generativelanguage.googleapis.com' port=443 local_address=None timeout=None socket_options=None
_trace.py:87 DEBUG:connect_tcp.complete return_value=<httpcore._backends.anyio.AnyIOStream object at 0x112ff9c70>
_trace.py:87 DEBUG:start_tls.started ssl_context=<ssl.SSLContext object at 0x11301c650> server_hostname='generativelanguage.googleapis.com' timeout=None
_trace.py:87 DEBUG:start_tls.complete return_value=<httpcore._backends.anyio.AnyIOStream object at 0x112f6f020>
_trace.py:87 DEBUG:send_request_headers.started request=<Request [b'POST']>
_trace.py:87 DEBUG:send_request_headers.complete
_trace.py:87 DEBUG:send_request_body.started request=<Request [b'POST']>
_trace.py:87 DEBUG:send_request_body.complete
_trace.py:87 DEBUG:receive_response_headers.started request=<Request [b'POST']>
_trace.py:87 DEBUG:receive_response_headers.complete return_value=(b'HTTP/1.1', 200, b'OK', [(b'Content-Type', b'application/json; charset=UTF-8'), (b'Vary', b'Origin'), (b'Vary', b'X-Origin'), (b'Vary', b'Referer'), (b'Content-Encoding', b'gzip'), (b'Date', b'Mon, 01 Dec 2025 05:58:06 GMT'), (b'Server', b'scaffolding on HTTPServer2'), (b'X-XSS-Protection', b'0'), (b'X-Frame-Options', b'SAMEORIGIN'), (b'X-Content-Type-Options', b'nosniff'), (b'Server-Timing', b'gfet4t7; dur=795'), (b'Alt-Svc', b'h3=":443"; ma=2592000,h3-29=":443"; ma=2592000'), (b'Transfer-Encoding', b'chunked')])
_client.py:1740 INFO:HTTP Request: POST https://generativelanguage.googleapis.com/v1beta/models/gemini-2.5-flash-lite:generateContent "HTTP/1.1 200 OK"
_trace.py:87 DEBUG:receive_response_body.started request=<Request [b'POST']>
_trace.py:87 DEBUG:receive_response_body.complete
_trace.py:87 DEBUG:response_closed.started
_trace.py:87 DEBUG:response_closed.complete
google_llm.py:186 INFO:Response received from the model.
google_llm.py:187 DEBUG:
LLM Response:
-----------------------------------------------------------
Text:
None
-----------------------------------------------------------
Function calls:
name: get_dict_from_query, args: {'method': 'Gynecomastia Surgery'}
-----------------------------------------------------------
Raw response:
{"sdk_http_response":{"headers":{"content-type":"application/json; charset=UTF-8","vary":"Origin, X-Origin, Referer","content-encoding":"gzip","date":"Mon, 01 Dec 2025 05:58:06 GMT","server":"scaffolding on HTTPServer2","x-xss-protection":"0","x-frame-options":"SAMEORIGIN","x-content-type-options":"nosniff","server-timing":"gfet4t7; dur=795","alt-svc":"h3=\":443\"; ma=2592000,h3-29=\":443\"; ma=2592000","transfer-encoding":"chunked"}},"candidates":[{"content":{"parts":[{"function_call":{"args":{"method":"Gynecomastia Surgery"},"name":"get_dict_from_query"}}],"role":"model"},"finish_reason":"STOP","index":0}],"model_version":"gemini-2.5-flash-lite","response_id":"bi4taeWCCuqPjMcPtZvMuQ4","usage_metadata":{"candidates_token_count":23,"prompt_token_count":205,"prompt_tokens_details":[{"modality":"TEXT","token_count":205}],"total_token_count":228}}
-----------------------------------------------------------

connectionpool.py:1049 DEBUG:Starting new HTTPS connection (1): eutils.ncbi.nlm.nih.gov:443
connectionpool.py:544 DEBUG:https://eutils.ncbi.nlm.nih.gov:443 "GET /entrez/eutils/esearch.fcgi?db=pubmed&term=Gynecomastia+Surgery+AND+review%5Bpt%5D&retmode=json&retmax=10&sort=pub+date HTTP/1.1" 200 None
google_llm.py:133 INFO:Sending out request, model: gemini-2.5-flash-lite, backend: GoogleLLMVariant.GEMINI_API, stream: False
google_llm.py:139 DEBUG:
LLM Request:
-----------------------------------------------------------
System Instruction:
Return a list of relevant research paper PMIDs based on the user's query. Focus on finding papers that directly address the user's topic. Focus on papers that are recent and highly cited. Return only the PMIDs in a comma-separated format.

You are an agent. Your internal name is "pubmed_search_agent". The description about you is "Searches for information using Pubmed".
-----------------------------------------------------------
Config:
{'tools': [{}]}
-----------------------------------------------------------
Contents:
{"parts":[{"text":"Gynecomastia Surgery"}],"role":"user"}
{"parts":[{"function_call":{"args":{"method":"Gynecomastia Surgery"},"name":"get_dict_from_query"}}],"role":"model"}
{"parts":[{"function_response":{"name":"get_dict_from_query","response":{"PMID":["41263895","40913704","40331995","40561872","40404535","40406639","40388094","40304653","39909181","39935942"]}}}],"role":"user"}
-----------------------------------------------------------
Functions:
get_dict_from_query: {'method': {'type': <Type.STRING: 'STRING'>}} 
-----------------------------------------------------------

_trace.py:87 DEBUG:send_request_headers.started request=<Request [b'POST']>
_trace.py:87 DEBUG:send_request_headers.complete
_trace.py:87 DEBUG:send_request_body.started request=<Request [b'POST']>
_trace.py:87 DEBUG:send_request_body.complete
_trace.py:87 DEBUG:receive_response_headers.started request=<Request [b'POST']>
_trace.py:87 DEBUG:receive_response_headers.complete return_value=(b'HTTP/1.1', 200, b'OK', [(b'Content-Type', b'application/json; charset=UTF-8'), (b'Vary', b'Origin'), (b'Vary', b'X-Origin'), (b'Vary', b'Referer'), (b'Content-Encoding', b'gzip'), (b'Date', b'Mon, 01 Dec 2025 05:58:07 GMT'), (b'Server', b'scaffolding on HTTPServer2'), (b'X-XSS-Protection', b'0'), (b'X-Frame-Options', b'SAMEORIGIN'), (b'X-Content-Type-Options', b'nosniff'), (b'Server-Timing', b'gfet4t7; dur=1002'), (b'Alt-Svc', b'h3=":443"; ma=2592000,h3-29=":443"; ma=2592000'), (b'Transfer-Encoding', b'chunked')])
_client.py:1740 INFO:HTTP Request: POST https://generativelanguage.googleapis.com/v1beta/models/gemini-2.5-flash-lite:generateContent "HTTP/1.1 200 OK"
_trace.py:87 DEBUG:receive_response_body.started request=<Request [b'POST']>
_trace.py:87 DEBUG:receive_response_body.complete
_trace.py:87 DEBUG:response_closed.started
_trace.py:87 DEBUG:response_closed.complete
google_llm.py:186 INFO:Response received from the model.
google_llm.py:187 DEBUG:
LLM Response:
-----------------------------------------------------------
Text:
Here are some relevant research papers on Gynecomastia Surgery: 41263895, 40913704, 40331995, 40561872, 40404535, 40406639, 40388094, 40304653, 39909181, 39935942.
-----------------------------------------------------------
Function calls:

-----------------------------------------------------------
Raw response:
{"sdk_http_response":{"headers":{"content-type":"application/json; charset=UTF-8","vary":"Origin, X-Origin, Referer","content-encoding":"gzip","date":"Mon, 01 Dec 2025 05:58:07 GMT","server":"scaffolding on HTTPServer2","x-xss-protection":"0","x-frame-options":"SAMEORIGIN","x-content-type-options":"nosniff","server-timing":"gfet4t7; dur=1002","alt-svc":"h3=\":443\"; ma=2592000,h3-29=\":443\"; ma=2592000","transfer-encoding":"chunked"}},"candidates":[{"content":{"parts":[{"text":"Here are some relevant research papers on Gynecomastia Surgery: 41263895, 40913704, 40331995, 40561872, 40404535, 40406639, 40388094, 40304653, 39909181, 39935942."}],"role":"model"},"finish_reason":"STOP","index":0}],"model_version":"gemini-2.5-flash-lite","response_id":"by4taaWyIcPmjMcPv-CnwQg","usage_metadata":{"candidates_token_count":112,"prompt_token_count":346,"prompt_tokens_details":[{"modality":"TEXT","token_count":346}],"total_token_count":458}}
-----------------------------------------------------------

google_llm.py:133 INFO:Sending out request, model: gemini-2.5-flash-lite, backend: GoogleLLMVariant.GEMINI_API, stream: False
google_llm.py:139 DEBUG:
LLM Request:
-----------------------------------------------------------
System Instruction:
 You are an expert research assistant writing reports for the general public.
     
    For research requests: 
    1. Use `pubmed_search_agent` to find relevant research papers.  
    2. Use `summarize_agent` to summarize the papers found.
    3. Write a concise report. Your report MUST include the PMIDs returned from `pubmed_search_agent`.
    4. Always use the tools provided; never fabricate information or citations.
    

You are an agent. Your internal name is "research_paper_finder_agent".
-----------------------------------------------------------
Config:
{'tools': [{}]}
-----------------------------------------------------------
Contents:
{"parts":[{"text":"I want to know more about Gynecomastia Surgery."}],"role":"user"}
{"parts":[{"function_call":{"args":{"request":"Gynecomastia Surgery"},"name":"pubmed_search_agent"}}],"role":"model"}
{"parts":[{"function_response":{"name":"pubmed_search_agent","response":{"result":"Here are some relevant research papers on Gynecomastia Surgery: 41263895, 40913704, 40331995, 40561872, 40404535, 40406639, 40388094, 40304653, 39909181, 39935942."}}}],"role":"user"}
-----------------------------------------------------------
Functions:
pubmed_search_agent: {'request': {'type': <Type.STRING: 'STRING'>}} 
summarize_agent: {'request': {'type': <Type.STRING: 'STRING'>}} 
-----------------------------------------------------------

_trace.py:87 DEBUG:send_request_headers.started request=<Request [b'POST']>
_trace.py:87 DEBUG:send_request_headers.complete
_trace.py:87 DEBUG:send_request_body.started request=<Request [b'POST']>
_trace.py:87 DEBUG:send_request_body.complete
_trace.py:87 DEBUG:receive_response_headers.started request=<Request [b'POST']>
_trace.py:87 DEBUG:receive_response_headers.complete return_value=(b'HTTP/1.1', 200, b'OK', [(b'Content-Type', b'application/json; charset=UTF-8'), (b'Vary', b'Origin'), (b'Vary', b'X-Origin'), (b'Vary', b'Referer'), (b'Content-Encoding', b'gzip'), (b'Date', b'Mon, 01 Dec 2025 05:58:08 GMT'), (b'Server', b'scaffolding on HTTPServer2'), (b'X-XSS-Protection', b'0'), (b'X-Frame-Options', b'SAMEORIGIN'), (b'X-Content-Type-Options', b'nosniff'), (b'Server-Timing', b'gfet4t7; dur=954'), (b'Alt-Svc', b'h3=":443"; ma=2592000,h3-29=":443"; ma=2592000'), (b'Transfer-Encoding', b'chunked')])
_client.py:1740 INFO:HTTP Request: POST https://generativelanguage.googleapis.com/v1beta/models/gemini-2.5-flash-lite:generateContent "HTTP/1.1 200 OK"
_trace.py:87 DEBUG:receive_response_body.started request=<Request [b'POST']>
_trace.py:87 DEBUG:receive_response_body.complete
_trace.py:87 DEBUG:response_closed.started
_trace.py:87 DEBUG:response_closed.complete
google_llm.py:186 INFO:Response received from the model.
google_llm.py:187 DEBUG:
LLM Response:
-----------------------------------------------------------
Text:
None
-----------------------------------------------------------
Function calls:
name: summarize_agent, args: {'request': 'Summarize the following papers about Gynecomastia Surgery: 41263895, 40913704, 40331995, 40561872, 40404535, 40406639, 40388094, 40304653, 39909181, 39935942.'}
-----------------------------------------------------------
Raw response:
{"sdk_http_response":{"headers":{"content-type":"application/json; charset=UTF-8","vary":"Origin, X-Origin, Referer","content-encoding":"gzip","date":"Mon, 01 Dec 2025 05:58:08 GMT","server":"scaffolding on HTTPServer2","x-xss-protection":"0","x-frame-options":"SAMEORIGIN","x-content-type-options":"nosniff","server-timing":"gfet4t7; dur=954","alt-svc":"h3=\":443\"; ma=2592000,h3-29=\":443\"; ma=2592000","transfer-encoding":"chunked"}},"candidates":[{"content":{"parts":[{"function_call":{"args":{"request":"Summarize the following papers about Gynecomastia Surgery: 41263895, 40913704, 40331995, 40561872, 40404535, 40406639, 40388094, 40304653, 39909181, 39935942."},"name":"summarize_agent"}}],"role":"model"},"finish_reason":"STOP","index":0}],"model_version":"gemini-2.5-flash-lite","response_id":"cC4tafGRIO_VjMcP3NGFyAg","usage_metadata":{"candidates_token_count":125,"prompt_token_count":359,"prompt_tokens_details":[{"modality":"TEXT","token_count":359}],"total_token_count":484}}
-----------------------------------------------------------

plugin_manager.py:96 INFO:Plugin 'logging_plugin' registered.
plugin_manager.py:96 INFO:Plugin 'reflect_retry_tool_plugin' registered.
mcp_session_manager.py:366 DEBUG:Created new session: stdio_session
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
types.py:2382 INFO:
Note: Conversion of fields that are not included in the JSONSchema class are ignored.
Json Schema is now supported natively by both Vertex AI and Gemini API. Users
are recommended to pass/receive Json Schema directly to/from the API. For example:
1. the counter part of GenerateContentConfig.response_schema is
   GenerateContentConfig.response_json_schema, which accepts [JSON
  Schema](https://json-schema.org/)
2. the counter part of FunctionDeclaration.parameters is
   FunctionDeclaration.parameters_json_schema, which accepts [JSON
   Schema](https://json-schema.org/)
3. the counter part of FunctionDeclaration.response is
   FunctionDeclaration.response_json_schema, which accepts [JSON
   Schema](https://json-schema.org/)

google_llm.py:133 INFO:Sending out request, model: gemini-2.5-flash-lite, backend: GoogleLLMVariant.GEMINI_API, stream: False
google_llm.py:139 DEBUG:
LLM Request:
-----------------------------------------------------------
System Instruction:
Use the provided PMIDs to fetch the full text of each research paper from Pubmed. Summarize the key findings of each paper in a concise manner. Ensure that each summary includes a proper citation with a link to the original article.

You are an agent. Your internal name is "summarize_agent". The description about you is "Summarizes research papers".
-----------------------------------------------------------
Config:
{'tools': [{}]}
-----------------------------------------------------------
Contents:
{"parts":[{"text":"Summarize the following papers about Gynecomastia Surgery: 41263895, 40913704, 40331995, 40561872, 40404535, 40406639, 40388094, 40304653, 39909181, 39935942."}],"role":"user"}
-----------------------------------------------------------
Functions:
pubmed_article_connections: {'sourcePmid': {'description': 'The PubMed Unique Identifier (PMID) of the source article for which to find connections or format citations. This PMID must be a valid number string.', 'pattern': '^\\d+$', 'type': <Type.STRING: 'STRING'>}, 'relationshipType': {'default': 'pubmed_similar_articles', 'description': "Specifies the type of connection or action: 'pubmed_similar_articles' (finds similar articles), 'pubmed_citedin' (finds citing articles), 'pubmed_references' (finds referenced articles), or 'citation_formats' (retrieves formatted citations).", 'enum': ['pubmed_similar_articles', 'pubmed_citedin', 'pubmed_references', 'citation_formats'], 'type': <Type.STRING: 'STRING'>}, 'maxRelatedResults': {'default': 5, 'description': 'Maximum number of related articles to retrieve for relationship-based searches. Default is 5, max is 50.', 'maximum': 50.0, 'type': <Type.INTEGER: 'INTEGER'>}, 'citationStyles': {'default': ['ris'], 'description': "An array of citation styles to format the source article into when 'relationshipType' is 'citation_formats'. Supported styles: 'ris', 'bibtex', 'apa_string', 'mla_string'. Default is ['ris'].", 'items': {'enum': ['ris', 'bibtex', 'apa_string', 'mla_string'], 'type': <Type.STRING: 'STRING'>}, 'type': <Type.ARRAY: 'ARRAY'>}} 
pubmed_fetch_contents: {'pmids': {'description': 'An array of PubMed Unique Identifiers (PMIDs) to fetch. Use this OR queryKey/webEnv.', 'items': {'pattern': '^\\d+$', 'type': <Type.STRING: 'STRING'>}, 'max_items': 200, 'type': <Type.ARRAY: 'ARRAY'>}, 'queryKey': {'description': 'Query key from ESearch history. Requires webEnv. Use this OR pmids.', 'type': <Type.STRING: 'STRING'>}, 'webEnv': {'description': 'Web environment from ESearch history. Requires queryKey. Use this OR pmids.', 'type': <Type.STRING: 'STRING'>}, 'retstart': {'description': '0-based index of the first record to retrieve. Used with queryKey/webEnv.', 'minimum': 0.0, 'type': <Type.INTEGER: 'INTEGER'>}, 'retmax': {'description': 'Maximum number of records to retrieve. Used with queryKey/webEnv.', 'minimum': 1.0, 'type': <Type.INTEGER: 'INTEGER'>}, 'detailLevel': {'default': 'abstract_plus', 'description': "Specifies the level of detail for the fetched content. Options: 'abstract_plus' (parsed details), 'full_xml' (raw PubMedArticle XML), 'medline_text' (MEDLINE format), 'citation_data' (minimal citation data). Defaults to 'abstract_plus'.", 'enum': ['abstract_plus', 'full_xml', 'medline_text', 'citation_data'], 'type': <Type.STRING: 'STRING'>}, 'includeMeshTerms': {'default': True, 'description': "Include MeSH terms in 'abstract_plus' and 'citation_data' results. Default: true.", 'type': <Type.BOOLEAN: 'BOOLEAN'>}, 'includeGrantInfo': {'default': False, 'description': "Include grant info in 'abstract_plus' results. Default: false.", 'type': <Type.BOOLEAN: 'BOOLEAN'>}, 'outputFormat': {'default': 'json', 'description': "Output format. 'json' (default) wraps data in a JSON object. 'raw_text' returns raw text for 'medline_text' or 'full_xml' detail levels.", 'enum': ['json', 'raw_text'], 'type': <Type.STRING: 'STRING'>}} 
pubmed_generate_chart: {'chartType': {'description': 'Specifies the type of chart to generate.', 'enum': ['bar', 'line', 'scatter', 'pie', 'doughnut', 'bubble', 'radar', 'polarArea'], 'type': <Type.STRING: 'STRING'>}, 'title': {'description': 'The main title displayed above the chart.', 'type': <Type.STRING: 'STRING'>}, 'width': {'default': 800, 'description': 'The width of the chart canvas in pixels.', 'type': <Type.INTEGER: 'INTEGER'>}, 'height': {'default': 600, 'description': 'The height of the chart canvas in pixels.', 'type': <Type.INTEGER: 'INTEGER'>}, 'dataValues': {'description': "An array of data objects to plot the chart (e.g., [{ 'year': '2020', 'articles': 150 }]).", 'items': {'type': <Type.OBJECT: 'OBJECT'>}, 'min_items': 1, 'type': <Type.ARRAY: 'ARRAY'>}, 'outputFormat': {'default': 'png', 'description': 'Specifies the output format for the chart.', 'enum': ['png'], 'type': <Type.STRING: 'STRING'>}, 'xField': {'description': 'The field name from `dataValues` for the X-axis.', 'type': <Type.STRING: 'STRING'>}, 'yField': {'description': 'The field name from `dataValues` for the Y-axis.', 'type': <Type.STRING: 'STRING'>}, 'seriesField': {'description': 'The field name for creating multiple data series on the same chart.', 'type': <Type.STRING: 'STRING'>}, 'sizeField': {'description': 'For bubble charts, the field name for encoding bubble size.', 'type': <Type.STRING: 'STRING'>}} 
pubmed_research_agent: {'project_title_suggestion': {'description': 'A concise and descriptive title for the research project.', 'min_length': 5, 'type': <Type.STRING: 'STRING'>}, 'primary_research_goal': {'description': 'The main scientific objective or central question the research aims to address (e.g., "To investigate the role of TREM2 in microglial response to amyloid-beta plaques").', 'min_length': 10, 'type': <Type.STRING: 'STRING'>}, 'research_keywords': {'description': 'Core scientific keywords or MeSH terms defining the research domain (e.g., ["neuroinflammation", "Alzheimer\'s disease", "TREM2"]).', 'items': {'min_length': 1, 'type': <Type.STRING: 'STRING'>}, 'min_items': 1, 'type': <Type.ARRAY: 'ARRAY'>}, 'organism_focus': {'description': 'Primary organism(s) or model systems (e.g., "Homo sapiens (iPSC-derived microglia)", "Mus musculus (5xFAD model)").', 'type': <Type.STRING: 'STRING'>}, 'p1_introduction_and_background': {'description': 'Brief overview of the research area, its significance, and relevant background information leading to this study.', 'type': <Type.STRING: 'STRING'>}, 'p1_specific_research_question': {'description': 'The precise, focused primary research question the study will answer.', 'type': <Type.STRING: 'STRING'>}, 'p1_knowledge_gap': {'description': 'Statement clearly identifying the specific gap in current knowledge this research addresses.', 'type': <Type.STRING: 'STRING'>}, 'p1_primary_hypothesis': {'description': 'The main, testable hypothesis. Should be clear, specific, and falsifiable.', 'type': <Type.STRING: 'STRING'>}, 'p1_secondary_questions_or_hypotheses': {'description': 'Any secondary questions or hypotheses to be explored.', 'items': {'type': <Type.STRING: 'STRING'>}, 'type': <Type.ARRAY: 'ARRAY'>}, 'p1_pubmed_search_strategy_description': {'description': 'Description of the primary literature search strategy (e.g., for PubMed), including key terms and database considerations.', 'type': <Type.STRING: 'STRING'>}, 'p1_literature_review_scope': {'description': 'The defined scope for the literature review (e.g., timeframes, study types, key themes).', 'type': <Type.STRING: 'STRING'>}, 'p1_lit_review_databases_and_approach': {'description': 'Key databases (e.g., PubMed, EMBASE) and the search approach (e.g., iterative queries, snowballing).', 'type': <Type.STRING: 'STRING'>}, 'p1_experimental_paradigm': {'description': "The overarching experimental design or study type (e.g., 'comparative multi-omics analysis', 'longitudinal cohort study').", 'type': <Type.STRING: 'STRING'>}, 'p1_data_acquisition_plan_existing_data': {'description': 'Strategy for identifying and retrieving relevant existing datasets (databases, data types, tools).', 'type': <Type.STRING: 'STRING'>}, 'p1_data_acquisition_plan_new_data': {'description': 'Plan for generating novel data (data types, experimental models, key procedures, deposition plan).', 'type': <Type.STRING: 'STRING'>}, 'p1_blast_utilization_plan': {'description': 'If applicable, how sequence alignment services (e.g., NCBI BLAST) will be used (purpose, programs, databases).', 'type': <Type.STRING: 'STRING'>}, 'p1_controls_and_rigor': {'description': 'Description of key experimental controls and measures to ensure scientific rigor and reproducibility.', 'type': <Type.STRING: 'STRING'>}, 'p1_methodological_challenges_and_mitigation': {'description': 'Anticipated methodological challenges and proposed mitigation strategies.', 'type': <Type.STRING: 'STRING'>}, 'p2_data_collection_methods_wet_lab': {'description': 'Specific wet-lab protocols if new data is generated (sample prep, treatments, instruments).', 'type': <Type.STRING: 'STRING'>}, 'p2_data_collection_methods_dry_lab': {'description': 'Execution details for data retrieval from databases (queries, tools, accessioning).', 'type': <Type.STRING: 'STRING'>}, 'p2_data_preprocessing_and_qc_plan': {'description': 'Pipeline for data cleaning, preprocessing (e.g., alignment, normalization), and quality control (metrics, thresholds, tools).', 'type': <Type.STRING: 'STRING'>}, 'p3_data_analysis_strategy': {'description': 'Core statistical and computational methods to analyze data and test hypotheses (tests, software, ML models if any).', 'type': <Type.STRING: 'STRING'>}, 'p3_bioinformatics_pipeline_summary': {'description': 'Summary of the bioinformatics pipeline for high-throughput data analysis (tools, downstream analyses).', 'type': <Type.STRING: 'STRING'>}, 'p3_results_interpretation_framework': {'description': 'Framework for evaluating findings against hypotheses (statistical significance, biological relevance).', 'type': <Type.STRING: 'STRING'>}, 'p3_comparison_with_literature_plan': {'description': 'Strategy for contextualizing results with existing literature and addressing discrepancies.', 'type': <Type.STRING: 'STRING'>}, 'p4_dissemination_manuscript_plan': {'description': 'Plan for manuscript preparation (core message, target journal profile, key figures).', 'type': <Type.STRING: 'STRING'>}, 'p4_dissemination_data_deposition_plan': {'description': 'Strategy for depositing data in public repositories (types, repositories, FAIR principles).', 'type': <Type.STRING: 'STRING'>}, 'p4_peer_review_and_publication_approach': {'description': 'Approach to journal submission and addressing peer review.', 'type': <Type.STRING: 'STRING'>}, 'p4_future_research_directions': {'description': 'Potential next steps, new questions, or translational applications arising from the research.', 'type': <Type.STRING: 'STRING'>}, 'cc_record_keeping_and_data_management': {'description': 'Plan for record-keeping, version control, data storage, and DMP.', 'type': <Type.STRING: 'STRING'>}, 'cc_collaboration_strategy': {'description': 'If applicable, strategy for collaboration, communication, roles, and authorship.', 'type': <Type.STRING: 'STRING'>}, 'cc_ethical_considerations': {'description': 'Ethical considerations, IRB/IACUC approval plans, data privacy, RCR training.', 'type': <Type.STRING: 'STRING'>}, 'include_detailed_prompts_for_agent': {'default': False, 'description': 'If true, the tool will add more detailed instructive prompts/guidance within the output fields for a research agent. If false (default), it will primarily structure the provided inputs with minimal additional prompting.', 'type': <Type.BOOLEAN: 'BOOLEAN'>}} 
pubmed_search_articles: {'queryTerm': {'description': 'The primary keyword or phrase to search for in PubMed. Must be at least 3 characters long.', 'min_length': 3, 'type': <Type.STRING: 'STRING'>}, 'maxResults': {'default': 20, 'description': "Maximum number of articles to retrieve. Corresponds to ESearch's 'retmax' parameter. Default is 20, max is 1000.", 'maximum': 1000.0, 'type': <Type.INTEGER: 'INTEGER'>}, 'sortBy': {'default': 'relevance', 'description': "Sorting criteria for results. Options: 'relevance' (default), 'pub_date', 'author', 'journal_name'.", 'enum': ['relevance', 'pub_date', 'author', 'journal_name'], 'type': <Type.STRING: 'STRING'>}, 'dateRange': {'description': 'Defines an optional date range for the search.', 'properties': {'minDate': {'description': 'The start date for the search range (YYYY, YYYY/MM, or YYYY/MM/DD).', 'pattern': '^\\d{4}(\\/\\d{2}(\\/\\d{2})?)?$', 'type': <Type.STRING: 'STRING'>}, 'maxDate': {'description': 'The end date for the search range (YYYY, YYYY/MM, or YYYY/MM/DD).', 'pattern': '^\\d{4}(\\/\\d{2}(\\/\\d{2})?)?$', 'type': <Type.STRING: 'STRING'>}, 'dateType': {'default': 'pdat', 'description': "The type of date to filter by: 'pdat' (Publication Date), 'mdat' (Modification Date), 'edat' (Entrez Date). Default is 'pdat'.", 'enum': ['pdat', 'mdat', 'edat'], 'type': <Type.STRING: 'STRING'>}}, 'type': <Type.OBJECT: 'OBJECT'>}, 'filterByPublicationTypes': {'description': 'An array of publication types to filter by (e.g., ["Review", "Clinical Trial"]).', 'items': {'type': <Type.STRING: 'STRING'>}, 'type': <Type.ARRAY: 'ARRAY'>}, 'fetchBriefSummaries': {'default': 0, 'description': 'Number of top PMIDs for which to fetch brief summaries using ESummary. Set to 0 to disable. Max 50. Default 0.', 'maximum': 50.0, 'minimum': 0.0, 'type': <Type.INTEGER: 'INTEGER'>}} 
-----------------------------------------------------------

_trace.py:87 DEBUG:connect_tcp.started host='generativelanguage.googleapis.com' port=443 local_address=None timeout=None socket_options=None
_trace.py:87 DEBUG:connect_tcp.complete return_value=<httpcore._backends.anyio.AnyIOStream object at 0x11303ed80>
_trace.py:87 DEBUG:start_tls.started ssl_context=<ssl.SSLContext object at 0x113059e50> server_hostname='generativelanguage.googleapis.com' timeout=None
_trace.py:87 DEBUG:start_tls.complete return_value=<httpcore._backends.anyio.AnyIOStream object at 0x112f2dd30>
_trace.py:87 DEBUG:send_request_headers.started request=<Request [b'POST']>
_trace.py:87 DEBUG:send_request_headers.complete
_trace.py:87 DEBUG:send_request_body.started request=<Request [b'POST']>
_trace.py:87 DEBUG:send_request_body.complete
_trace.py:87 DEBUG:receive_response_headers.started request=<Request [b'POST']>
_trace.py:87 DEBUG:receive_response_headers.complete return_value=(b'HTTP/1.1', 200, b'OK', [(b'Content-Type', b'application/json; charset=UTF-8'), (b'Vary', b'Origin'), (b'Vary', b'X-Origin'), (b'Vary', b'Referer'), (b'Content-Encoding', b'gzip'), (b'Date', b'Mon, 01 Dec 2025 05:58:11 GMT'), (b'Server', b'scaffolding on HTTPServer2'), (b'X-XSS-Protection', b'0'), (b'X-Frame-Options', b'SAMEORIGIN'), (b'X-Content-Type-Options', b'nosniff'), (b'Server-Timing', b'gfet4t7; dur=1043'), (b'Alt-Svc', b'h3=":443"; ma=2592000,h3-29=":443"; ma=2592000'), (b'Transfer-Encoding', b'chunked')])
_client.py:1740 INFO:HTTP Request: POST https://generativelanguage.googleapis.com/v1beta/models/gemini-2.5-flash-lite:generateContent "HTTP/1.1 200 OK"
_trace.py:87 DEBUG:receive_response_body.started request=<Request [b'POST']>
_trace.py:87 DEBUG:receive_response_body.complete
_trace.py:87 DEBUG:response_closed.started
_trace.py:87 DEBUG:response_closed.complete
google_llm.py:186 INFO:Response received from the model.
google_llm.py:187 DEBUG:
LLM Response:
-----------------------------------------------------------
Text:
None
-----------------------------------------------------------
Function calls:
name: pubmed_fetch_contents, args: {'pmids': ['41263895', '40913704', '40331995', '40561872', '40404535', '40406639', '40388094', '40304653', '39909181', '39935942']}
-----------------------------------------------------------
Raw response:
{"sdk_http_response":{"headers":{"content-type":"application/json; charset=UTF-8","vary":"Origin, X-Origin, Referer","content-encoding":"gzip","date":"Mon, 01 Dec 2025 05:58:11 GMT","server":"scaffolding on HTTPServer2","x-xss-protection":"0","x-frame-options":"SAMEORIGIN","x-content-type-options":"nosniff","server-timing":"gfet4t7; dur=1043","alt-svc":"h3=\":443\"; ma=2592000,h3-29=\":443\"; ma=2592000","transfer-encoding":"chunked"}},"candidates":[{"content":{"parts":[{"function_call":{"args":{"pmids":["41263895","40913704","40331995","40561872","40404535","40406639","40388094","40304653","39909181","39935942"]},"name":"pubmed_fetch_contents"}}],"role":"model"},"finish_reason":"STOP","index":0}],"model_version":"gemini-2.5-flash-lite","response_id":"cy4taYDVEqi1jMcPp6qvuQg","usage_metadata":{"candidates_token_count":115,"prompt_token_count":3812,"prompt_tokens_details":[{"modality":"TEXT","token_count":3812}],"total_token_count":3927}}
-----------------------------------------------------------

base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
google_llm.py:133 INFO:Sending out request, model: gemini-2.5-flash-lite, backend: GoogleLLMVariant.GEMINI_API, stream: False
google_llm.py:139 DEBUG:
LLM Request:
-----------------------------------------------------------
System Instruction:
Use the provided PMIDs to fetch the full text of each research paper from Pubmed. Summarize the key findings of each paper in a concise manner. Ensure that each summary includes a proper citation with a link to the original article.

You are an agent. Your internal name is "summarize_agent". The description about you is "Summarizes research papers".
-----------------------------------------------------------
Config:
{'tools': [{}]}
-----------------------------------------------------------
Contents:
{"parts":[{"text":"Summarize the following papers about Gynecomastia Surgery: 41263895, 40913704, 40331995, 40561872, 40404535, 40406639, 40388094, 40304653, 39909181, 39935942."}],"role":"user"}
{"parts":[{"function_call":{"args":{"pmids":["41263895","40913704","40331995","40561872","40404535","40406639","40388094","40304653","39909181","39935942"]},"name":"pubmed_fetch_contents"}}],"role":"model"}
{"parts":[{"function_response":{"name":"pubmed_fetch_contents","response":{"content":[{"type":"text","text":"{\"requestedPmids\":[\"41263895\",\"40913704\",\"40331995\",\"40561872\",\"40404535\",\"40406639\",\"40388094\",\"40304653\",\"39909181\",\"39935942\"],\"articles\":[{\"pmid\":\"41263895\",\"title\":\"Content and Readability Analysis of Patient-Reported Outcome Measures for Gynecomastia: A Systematic Review.\",\"abstractText\":\"Gynecomastia, characterized by the benign enlargement of male breast tissue, has a lifetime prevalence of 65% and can significantly impact quality of life and psychosocial well-being. Although most cases resolve spontaneously within 1 to 3 years, surgical intervention is often necessary for patients experiencing persistent symptoms or distress. Understanding patient perspectives via patient-reported outcome measures (PROMs) is critical for evaluating the success of medical or surgical interventions in addressing aesthetic concerns, psychosocial functioning, and health-related quality of life (HRQOL). However, a systematic review of available PROMs specific to gynecomastia is lacking. This study aims to identify and analyze existing PROMs used for patients with gynecomastia and to assess PROM content and readability. This systematic review followed PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines, and searches were performed across 4 databases: PubMed, EMBASE, CINAHL, and Scopus. The search strategy resulted in 22 studies and 23 unique PROMs. Following a structured domain framework with field definitions, content comparison was performed for 908 PROM items across 5 domains: objective appearance, self-perception, HRQOL, social outcomes, and intervention satisfaction. Readability was assessed using the Simple Measure of Gobbledygook and Flesch-Kincaid indices. Results indicated that although some PROMs adequately address key domains such as objective appearance and self-perception, significant gaps remain in comprehensively capturing the full spectrum of HRQOL and social outcomes among patients with gynecomastia. Additionally, readability indices for nearly all PROMs exceed the recommended grade level for the general population, thereby highlighting the need for a new gynecomastia-specific instrument that can be used for pediatric, adolescent, and adult populations.\",\"authors\":[{\"lastName\":\"Vaile\",\"firstName\":\"John R\",\"initials\":\"JR\"},{\"lastName\":\"Cordray\",\"firstName\":\"Holly\",\"initials\":\"H\",\"affiliation\":\"University of Pennsylvania, Philadelphia, PA.\"},{\"lastName\":\"Terry\",\"firstName\":\"Peyton H\",\"initials\":\"PH\",\"affiliation\":\"University of Pennsylvania, Philadelphia, PA.\"},{\"lastName\":\"Struble\",\"firstName\":\"Sarah L\",\"initials\":\"SL\"},{\"lastName\":\"Chang\",\"firstName\":\"Ashley E\",\"initials\":\"AE\",\"affiliation\":\"University of Pennsylvania, Philadelphia, PA.\"},{\"lastName\":\"Friedman\",\"firstName\":\"Leigh\",\"initials\":\"L\",\"affiliation\":\"Beth Israel Deaconess Medical Center, Boston, MA.\"},{\"lastName\":\"Reed\",\"firstName\":\"Julie\",\"initials\":\"J\",\"affiliation\":\"Children's Hospital of Philadelphia.\"},{\"lastName\":\"Ligh\",\"firstName\":\"Cassandra A\",\"initials\":\"CA\"}],\"journalInfo\":{\"title\":\"Annals of plastic surgery\",\"isoAbbreviation\":\"Ann Plast Surg\",\"volume\":\"95\",\"issue\":\"6\",\"pages\":\"744-751\",\"publicationDate\":{\"year\":\"2025\",\"month\":\"Dec\",\"day\":\"1\"}},\"publicationTypes\":[\"Journal Article\",\"Systematic Review\"],\"doi\":\"10.1097/SAP.0000000000004482\",\"articleDates\":[{\"dateType\":\"Electronic\",\"year\":\"2025\",\"month\":\"7\",\"day\":\"31\"}],\"meshTerms\":[{\"descriptorName\":\"Humans\",\"descriptorUi\":\"D006801\",\"isMajorTopic\":false},{\"descriptorName\":\"Gynecomastia\",\"descriptorUi\":\"D006177\",\"qualifierName\":\"psychology\",\"qualifierUi\":\"Q000523\",\"isMajorTopic\":true},{\"descriptorName\":\"Patient Reported Outcome Measures\",\"descriptorUi\":\"D000071066\",\"isMajorTopic\":true},{\"descriptorName\":\"Male\",\"descriptorUi\":\"D008297\",\"isMajorTopic\":false},{\"descriptorName\":\"Quality of Life\",\"descriptorUi\":\"D011788\",\"isMajorTopic\":true},{\"descriptorName\":\"Comprehension\",\"descriptorUi\":\"D032882\",\"isMajorTopic\":true}]},{\"pmid\":\"40913704\",\"title\":\"Male breast MRI: a review of different pathological conditions.\",\"abstractText\":\"The male breast is predisposed to be affected by many of the same pathological processes as the female breast is. The diagnosis of male breast pathologies is generally achievable when clinical evaluation is combined with standard breast imaging methods such as mammography and ultrasound. Magnetic resonance imaging is also a valuable tool in diagnosing the main pathologies affecting the male breast, especially for evaluating pre- and post-surgical treatments and follow-up. However, although this technique has been sufficiently regulated and adopted by many breast radiologists for female breast imaging, its application in the diagnosis of male breast pathologies remains limited to a few specialized centers. This article, based on a retrospective analysis of the experience of the University of Verona, explores various aspects of male breast diseases, including benign conditions such as gynecomastia and breast implant ruptures in transgender women as well as malignant entities such as male breast cancer. Emphasis is placed on the distinctive morphological features, enhancement patterns and kinetics observed in male breast lesions on dynamic contrast-enhanced MRI. This article provides a comprehensive overview of the application of MRI in male breast disease assessment, highlighting the potential role of MRI as a complementary tool to traditional breast imaging techniques.\",\"authors\":[{\"lastName\":\"Barillari\",\"firstName\":\"Marco\",\"initials\":\"M\",\"affiliation\":\"Department of Diagnostic and Public Health, Section of Radiology, University of Verona, P.le L.A. Scuro 10, 37134, Verona, Italy.\"},{\"lastName\":\"Zanutto\",\"firstName\":\"Piero\",\"initials\":\"P\",\"affiliation\":\"Department of Diagnostic and Public Health, Section of Radiology, University of Verona, P.le L.A. Scuro 10, 37134, Verona, Italy. piero.zanutto@gmail.com.\"},{\"lastName\":\"Pellini\",\"firstName\":\"Francesca\",\"initials\":\"F\",\"affiliation\":\"Department of Breast Surgery, Ospedale Civile Maggiore AOUI Verona, P.le A. Stefani 1, 3716, Verona, Italy.\"},{\"lastName\":\"Fiorio\",\"firstName\":\"Elena\",\"initials\":\"E\",\"affiliation\":\"Department of Oncology, Ospedale Civile Maggiore AOUI Verona, P.le A. Stefani 1, 3716, Verona, Italy.\"},{\"lastName\":\"Deguidi\",\"firstName\":\"Giulia\",\"initials\":\"G\",\"affiliation\":\"Department of Breast Surgery, Ospedale Civile Maggiore AOUI Verona, P.le A. Stefani 1, 3716, Verona, Italy.\"},{\"lastName\":\"Invento\",\"firstName\":\"Alessandra\",\"initials\":\"A\",\"affiliation\":\"Department of Breast Surgery, Ospedale Civile Maggiore AOUI Verona, P.le A. Stefani 1, 3716, Verona, Italy.\"},{\"lastName\":\"Nottegar\",\"firstName\":\"Alessia\",\"initials\":\"A\",\"affiliation\":\"Department of Diagnostic and Public Health, Section of Pathology, University of Verona, P.le L.A. Scuro 10, 37134, Verona, Italy.\"},{\"lastName\":\"D'Onofrio\",\"firstName\":\"Mirko\",\"initials\":\"M\",\"affiliation\":\"Department of Diagnostic and Public Health, Section of Radiology, University of Verona, P.le L.A. Scuro 10, 37134, Verona, Italy.\"},{\"lastName\":\"Mansueto\",\"firstName\":\"Giancarlo\",\"initials\":\"G\",\"affiliation\":\"Department of Diagnostic and Public Health, Section of Radiology, University of Verona, P.le L.A. Scuro 10, 37134, Verona, Italy.\"}],\"journalInfo\":{\"title\":\"La Radiologia medica\",\"isoAbbreviation\":\"Radiol Med\",\"volume\":\"130\",\"issue\":\"11\",\"pages\":\"1752-1766\",\"publicationDate\":{\"year\":\"2025\",\"month\":\"Nov\"}},\"publicationTypes\":[\"Journal Article\",\"Review\"],\"doi\":\"10.1007/s11547-025-02084-x\",\"articleDates\":[{\"dateType\":\"Electronic\",\"year\":\"2025\",\"month\":\"9\",\"day\":\"6\"}],\"meshTerms\":[{\"descriptorName\":\"Humans\",\"descriptorUi\":\"D006801\",\"isMajorTopic\":false},{\"descriptorName\":\"Magnetic Resonance Imaging\",\"descriptorUi\":\"D008279\",\"qualifierName\":\"methods\",\"qualifierUi\":\"Q000379\",\"isMajorTopic\":true},{\"descriptorName\":\"Male\",\"descriptorUi\":\"D008297\",\"isMajorTopic\":false},{\"descriptorName\":\"Breast Neoplasms, Male\",\"descriptorUi\":\"D018567\",\"qualifierName\":\"diagnostic imaging\",\"qualifierUi\":\"Q000000981\",\"isMajorTopic\":false},{\"descriptorName\":\"Breast Diseases\",\"descriptorUi\":\"D001941\",\"qualifierName\":\"diagnostic imaging\",\"qualifierUi\":\"Q000000981\",\"isMajorTopic\":true},{\"descriptorName\":\"Contrast Media\",\"descriptorUi\":\"D003287\",\"isMajorTopic\":false},{\"descriptorName\":\"Gynecomastia\",\"descriptorUi\":\"D006177\",\"qualifierName\":\"diagnostic imaging\",\"qualifierUi\":\"Q000000981\",\"isMajorTopic\":false},{\"descriptorName\":\"Breast Implants\",\"descriptorUi\":\"D018427\",\"qualifierName\":\"adverse effects\",\"qualifierUi\":\"Q000009\",\"isMajorTopic\":false},{\"descriptorName\":\"Retrospective Studies\",\"descriptorUi\":\"D012189\",\"isMajorTopic\":false}]},{\"pmid\":\"40331995\",\"title\":\"Diseases of the Male Breast: Gynecomastia and Breast Cancer.\",\"abstractText\":\"BACKGROUND: Gynecomastia (GM) is the most common abnormality of the male breast; it is benign and usually bilateral. GM is a manifestation of disease and not a diagnosis in itself. An important differential diagnosis of unilateral GM is breast cancer.\\n\\nMETHODS: This narrative review is based on pertinent publications from 2010 onward that were retrieved by a PubMed search, with special attention to the guidelines of the AWMF and the European Academy of Andrology (EAA) and the recommendations of the German Society for Gynecology and Obstetrics.\\n\\nRESULTS: GM can occur physiologically in newborns, during puberty, and in men over age 65. The basic diagnostic evaluation of GM consists of a thorough history and physical examination (especially of the breast area and genitals), breast and testicular sonography, and laboratory testing for total testosterone (tT), estradiol (E2), luteinizing hormone (LH), human chorionic gonadotropin (hCG), and prolactin (PRL) levels. Further tests to be carried out as indicated according to the clinical findings include the determination of follicle-stimulating hormone (FSH), thyroid-stimulating hormone (TSH), fT4, alpha-1-fetoprotein (AFP), dehydroepiandrosterone (DHEA), and free testosterone (fT) levels, liver and kidney function tests, chromosomal analysis, and supplementary imaging procedures. The treatment depends on the underlying disease and the severity of symptoms, ranging from further observation alone to pharmacotherapy and surgery. Approximately 700 men receive a diagnosis of breast cancer each year in Germany. Because breast cancer in men is rare, there are no pertinent studies, and its treatment is analogous to the treatment of breast cancer in women as recommended in the guidelines.\\n\\nCONCLUSION: Men should be included in clinical trials of treatment for breast cancer whenever this is fea - sible, so that the evidence base can be enlarged and men can be given access to innovative treatment methods.\",\"authors\":[{\"lastName\":\"Faridi\",\"firstName\":\"Andree\",\"initials\":\"A\",\"affiliation\":\"Department of Senology and Breast Center, University Hospital Bonn, Bonn, Germany; Department of Gynecology and Obstetrics at Klinikum S&#xfc;dstadt, University Rostock, Rostock, Germany.\"},{\"lastName\":\"Gerber\",\"firstName\":\"Bernd\",\"initials\":\"B\"},{\"lastName\":\"Hartmann\",\"firstName\":\"Steffi\",\"initials\":\"S\"}],\"journalInfo\":{\"title\":\"Deutsches Arzteblatt international\",\"isoAbbreviation\":\"Dtsch Arztebl Int\",\"volume\":\"122\",\"issue\":\"15\",\"pages\":\"406-411\",\"publicationDate\":{\"year\":\"2025\",\"month\":\"Jul\",\"day\":\"25\"}},\"publicationTypes\":[\"Journal Article\",\"Review\"],\"doi\":\"10.3238/arztebl.m2025.0071\",\"meshTerms\":[{\"descriptorName\":\"Humans\",\"descriptorUi\":\"D006801\",\"isMajorTopic\":false},{\"descriptorName\":\"Gynecomastia\",\"descriptorUi\":\"D006177\",\"qualifierName\":\"diagnosis\",\"qualifierUi\":\"Q000175\",\"isMajorTopic\":true},{\"descriptorName\":\"Male\",\"descriptorUi\":\"D008297\",\"isMajorTopic\":false},{\"descriptorName\":\"Breast Neoplasms, Male\",\"descriptorUi\":\"D018567\",\"qualifierName\":\"diagnosis\",\"qualifierUi\":\"Q000175\",\"isMajorTopic\":true},{\"descriptorName\":\"Diagnosis, Differential\",\"descriptorUi\":\"D003937\",\"isMajorTopic\":false}]},{\"pmid\":\"40561872\",\"title\":\"[Management strategies for gynecomastia in patients with prostate cancer treated with androgen receptor pathway inhibitors].\",\"abstractText\":\"This review aims to evaluate the incidence, clinical impact, and available therapeutic options for the management of gynecomastia induced by hormonal therapy, particularly in the era of androgen receptor pathway inhibitors, in patients with prostate cancer. We analysed data from clinical trials evaluating the incidence of gynecomastia under androgen receptor pathway inhibitors and the efficacy of both prophylactic and curative strategies, primarily tamoxifen and male breast radiotherapy, in patients receiving bicalutamide. Androgen receptor pathway inhibitors monotherapy is associated with high rates of gynecomastia (34 to 55&#xa0;%), whereas combining androgen receptor pathway inhibitors with chemical castration significantly reduces this risk. Prophylactic tamoxifen significantly decreases gynecomastia incidence (down to 10&#xa0;% versus 73&#xa0;% without treatment) with good overall tolerance; prophylactic breast radiotherapy also shows efficacy. In the curative setting, tamoxifen appears more effective than radiotherapy, while surgery remains an invasive fallback option. However, extrapolating results obtained with bicalutamide to second-generation androgen receptor pathway inhibitors remains uncertain due to pharmacological and clinical differences. Gynecomastia could become a major complication of androgen receptor pathway inhibitors monotherapy. To date, tamoxifen and prophylactic breast radiotherapy are the most validated strategies, with the former appearing more effective. Further studies are needed to confirm their specific efficacy and safety in patients treated with androgen receptor pathway inhibitors.\",\"authors\":[{\"lastName\":\"Vibert\",\"firstName\":\"Nassim\",\"initials\":\"N\",\"affiliation\":\"Service de radioth&#xe9;rapie, institut Bergoni&#xe9;, 229, cour de l'Argonne, 33076 Bordeaux, France. Electronic address: n.vibert@bordeaux.unicancer.fr.\"},{\"lastName\":\"Achard\",\"firstName\":\"V&#xe9;rane\",\"initials\":\"V\",\"affiliation\":\"Service de radioth&#xe9;rapie, institut Bergoni&#xe9;, 229, cour de l'Argonne, 33076 Bordeaux, France; Universit&#xe9; de Gen&#xe8;ve, rue du G&#xe9;n&#xe9;ral-Dufour 24, 1211 Gen&#xe8;ve, Suisse.\"},{\"lastName\":\"Pouvreau\",\"firstName\":\"Pierre\",\"initials\":\"P\",\"affiliation\":\"Service de radioth&#xe9;rapie, institut Bergoni&#xe9;, 229, cour de l'Argonne, 33076 Bordeaux, France.\"},{\"lastName\":\"Huck\",\"firstName\":\"Constance\",\"initials\":\"C\",\"affiliation\":\"Service de radioth&#xe9;rapie, institut Bergoni&#xe9;, 229, cour de l'Argonne, 33076 Bordeaux, France.\"},{\"lastName\":\"Khalifa\",\"firstName\":\"Jonathan\",\"initials\":\"J\",\"affiliation\":\"Service de radioth&#xe9;rapie, Institut universitaire du cancer de Toulouse-Oncopole, institut Claudius-Regaud, 1, avenue Ir&#xe8;ne-Joliot-Curie, 31100 Toulouse, France.\"},{\"lastName\":\"Sargos\",\"firstName\":\"Paul\",\"initials\":\"P\",\"affiliation\":\"Service de radioth&#xe9;rapie, institut Bergoni&#xe9;, 229, cour de l'Argonne, 33076 Bordeaux, France; Service de radioth&#xe9;rapie, Amethyst Radiotherapy Group, 65, avenue Foch, 92250 La Garenne-Colombes, France.\"}],\"journalInfo\":{\"title\":\"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique\",\"isoAbbreviation\":\"Cancer Radiother\",\"volume\":\"29\",\"issue\":\"4\",\"pages\":\"104665\",\"publicationDate\":{\"year\":\"2025\",\"month\":\"Jul\"}},\"publicationTypes\":[\"English Abstract\",\"Journal Article\",\"Review\"],\"doi\":\"10.1016/j.canrad.2025.104665\",\"articleDates\":[{\"dateType\":\"Electronic\",\"year\":\"2025\",\"month\":\"6\",\"day\":\"24\"}],\"meshTerms\":[{\"descriptorName\":\"Humans\",\"descriptorUi\":\"D006801\",\"isMajorTopic\":false},{\"descriptorName\":\"Male\",\"descriptorUi\":\"D008297\",\"isMajorTopic\":false},{\"descriptorName\":\"Gynecomastia\",\"descriptorUi\":\"D006177\",\"qualifierName\":\"chemically induced\",\"qualifierUi\":\"Q000139\",\"isMajorTopic\":true},{\"descriptorName\":\"Prostatic Neoplasms\",\"descriptorUi\":\"D011471\",\"qualifierName\":\"drug therapy\",\"qualifierUi\":\"Q000188\",\"isMajorTopic\":true},{\"descriptorName\":\"Nitriles\",\"descriptorUi\":\"D009570\",\"qualifierName\":\"adverse effects\",\"qualifierUi\":\"Q000009\",\"isMajorTopic\":false},{\"descriptorName\":\"Anilides\",\"descriptorUi\":\"D000813\",\"qualifierName\":\"adverse effects\",\"qualifierUi\":\"Q000009\",\"isMajorTopic\":false},{\"descriptorName\":\"Tosyl Compounds\",\"descriptorUi\":\"D014105\",\"qualifierName\":\"adverse effects\",\"qualifierUi\":\"Q000009\",\"isMajorTopic\":false},{\"descriptorName\":\"Androgen Antagonists\",\"descriptorUi\":\"D000726\",\"qualifierName\":\"adverse effects\",\"qualifierUi\":\"Q000009\",\"isMajorTopic\":true},{\"descriptorName\":\"Tamoxifen\",\"descriptorUi\":\"D013629\",\"qualifierName\":\"therapeutic use\",\"qualifierUi\":\"Q000627\",\"isMajorTopic\":false},{\"descriptorName\":\"Androgen Receptor Antagonists\",\"descriptorUi\":\"D059002\",\"qualifierName\":\"adverse effects\",\"qualifierUi\":\"Q000009\",\"isMajorTopic\":true},{\"descriptorName\":\"Receptors, Androgen\",\"descriptorUi\":\"D011944\",\"isMajorTopic\":false},{\"descriptorName\":\"Antineoplastic Agents, Hormonal\",\"descriptorUi\":\"D018931\",\"qualifierName\":\"adverse effects\",\"qualifierUi\":\"Q000009\",\"isMajorTopic\":false}]},{\"pmid\":\"40404535\",\"title\":\"Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life-A Systematic Review and Meta-analysis.\",\"abstractText\":\"BACKGROUND AND OBJECTIVE: Androgen receptor pathway inhibitors (ARPIs) as monotherapy are studied increasingly across prostate cancer disease states. We aimed to evaluate the safety, oncologic efficacy, and quality of life (QoL) of ARPI monotherapy as compared with ARPI + androgen deprivation therapy (ADT) and ADT alone.\\n\\nMETHODS: PubMed/Medline, Embase, and Cochrane/Central were queried through June 2024 for clinical trials. The primary outcomes were the rates of adverse events (AEs) presented as risk ratios (RRs); the secondary outcomes included efficacy and QoL.\\n\\nKEY FINDINGS AND LIMITATIONS: We synthesized data from 2015 men, retrieved from 17 studies. The incidence of any AEs was similar between patients on ARPIs, ARPI + ADT (RR: 1.01, 95% confidence interval [CI]: 1-1.02, p&#xa0;=&#xa0;0.08), and ADT (RR: 1.01, 95% CI: 0.98-1.04, p&#xa0;=&#xa0;0.3). The incidence of grade &#x2265;3 AEs was higher in patients on ARPI monotherapy than in those on ADT (RR: 1.18, 95% CI: 1.11-1.24, p&#xa0;<&#xa0;0.01), driven mainly by fatigue and cardiovascular toxicity. There was no statistically significant difference in grade &#x2265;3 AEs between patients treated with ARPIs and ARPI + ADT (RR: 1.07, 95% CI: 0.87-1.3, p&#xa0;=&#xa0;0.4). ARPI monotherapy led to a lower incidence of hot flushes (RR: 0.4, 95% CI: 0.18-0.89, p&#xa0;=&#xa0;0.03) but higher incidences of breast pain (RR: 6.03, 95% CI: 3.34-10.88, p&#xa0;<&#xa0;0.01) and gynecomastia (RR: 5.73, 95% CI: 3.79-8.66, p&#xa0;<&#xa0;0.01) than treatment with ARPI + ADT. ARPIs demonstrated promising oncologic efficacy for patients with biochemical recurrence, while maintaining favorable overall and sexual QoL.\\n\\nCONCLUSIONS AND CLINICAL IMPLICATIONS: ARPI monotherapy results in overall similar toxicities for ARPI + ADT and ADT alone. The specific AE pattern of each combination can serve as a basis to tailor therapy to each patient's needs and wishes.\",\"authors\":[{\"lastName\":\"Fazekas\",\"firstName\":\"Tam&#xe1;s\",\"initials\":\"T\",\"affiliation\":\"Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Semmelweis University, Budapest, Hungary; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.\"},{\"lastName\":\"Miszczyk\",\"firstName\":\"Marcin\",\"initials\":\"M\",\"affiliation\":\"Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Collegium Medicum, Faculty of Medicine, WSB University, D&#x105;browa G&#xf3;rnicza, Poland.\"},{\"lastName\":\"Giesen\",\"firstName\":\"Alexander\",\"initials\":\"A\",\"affiliation\":\"Department of Urology, University Hospitals Leuven, Leuven, Belgium; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.\"},{\"lastName\":\"K&#xf3;i\",\"firstName\":\"Tam&#xe1;s\",\"initials\":\"T\",\"affiliation\":\"Centre for Translational Medicine, Semmelweis University, Budapest, Hungary; Department of Stochastics, Institute of Mathematics, Budapest University of Technology and Economics, Budapest, Hungary.\"},{\"lastName\":\"Zattoni\",\"firstName\":\"Fabio\",\"initials\":\"F\",\"affiliation\":\"Department of Surgery, Oncology, and Gastroenterology - Urology Clinic, University of Padua, Padua, Italy; Department of Medicine (DIMED), University of Padua, Padova, Italy.\"},{\"lastName\":\"Rodriguez-Sanchez\",\"firstName\":\"Lara\",\"initials\":\"L\",\"affiliation\":\"Department of Urology, Institut Mutualiste Montsouris, Paris, France.\"},{\"lastName\":\"Yanagisawa\",\"firstName\":\"Takafumi\",\"initials\":\"T\",\"affiliation\":\"Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.\"},{\"lastName\":\"Matsukawa\",\"firstName\":\"Akihiro\",\"initials\":\"A\",\"affiliation\":\"Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.\"},{\"lastName\":\"Szarvas\",\"firstName\":\"Tibor\",\"initials\":\"T\",\"affiliation\":\"Department of Urology, Semmelweis University, Budapest, Hungary; Department of Urology, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.\"},{\"lastName\":\"Kryst\",\"firstName\":\"Piotr\",\"initials\":\"P\",\"affiliation\":\"Second Department of Urology, Centre of Postgraduate Medical Education, Warsaw, Poland.\"},{\"lastName\":\"Rivas\",\"firstName\":\"Juan G&#xf3;mez\",\"initials\":\"JG\",\"affiliation\":\"European Association of Urology Young Academic Urologists, Arnhem, The Netherlands; Department of Urology, Hospital Clinico San Carlos, Madrid, Spain.\"},{\"lastName\":\"Merseburger\",\"firstName\":\"Axel S\",\"initials\":\"AS\",\"affiliation\":\"Department of Urology, University Hospital Schleswig-Holstein, L&#xfc;beck, Germany.\"},{\"lastName\":\"Santis\",\"firstName\":\"Maria De\",\"initials\":\"M\",\"affiliation\":\"Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Charit&#xe9; Universit&#xe4;tsmedizin Berlin, Berlin, Germany.\"},{\"lastName\":\"Joniau\",\"firstName\":\"Steven\",\"initials\":\"S\",\"affiliation\":\"Department of Urology, University Hospitals Leuven, Leuven, Belgium; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.\"},{\"lastName\":\"Briganti\",\"firstName\":\"Alberto\",\"initials\":\"A\",\"affiliation\":\"Vita-Salute San Raffaele University, Milan, Italy; Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.\"},{\"lastName\":\"Marra\",\"firstName\":\"Giancarlo\",\"initials\":\"G\",\"affiliation\":\"Division of Urology, Department of Surgical Sciences, Molinette Hospital, Citt&#xe0; della Salute E della Scienza and University of Turin, Turin, Italy.\"},{\"lastName\":\"Nyir&#xe1;dy\",\"firstName\":\"P&#xe9;ter\",\"initials\":\"P\",\"affiliation\":\"Department of Urology, Semmelweis University, Budapest, Hungary; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.\"},{\"lastName\":\"Gandaglia\",\"firstName\":\"Giorgio\",\"initials\":\"G\",\"affiliation\":\"Second Department of Urology, Centre of Postgraduate Medical Education, Warsaw, Poland; Vita-Salute San Raffaele University, Milan, Italy; Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.\"},{\"lastName\":\"Shariat\",\"firstName\":\"Shahrokh F\",\"initials\":\"SF\",\"affiliation\":\"Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Semmelweis University, Budapest, Hungary; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czechia; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Research Centre for Evidence Medicine, Urology Department, Tabriz University of Medical Sciences, Tabriz, Iran; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Electronic address: shahrokh.shariat@meduniwien.ac.at.\"},{\"lastName\":\"Rajwa\",\"firstName\":\"Pawel\",\"initials\":\"P\",\"affiliation\":\"Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Division of Surgery and Interventional Science, University College London, London, UK; Second Department of Urology, Centre of Postgraduate Medical Education, Warsaw, Poland.\"},{\"collectiveName\":\"EAU-YAU Prostate Cancer Working Group\"}],\"journalInfo\":{\"title\":\"European urology focus\",\"isoAbbreviation\":\"Eur Urol Focus\",\"volume\":\"\",\"issue\":\"\",\"pages\":\"\",\"publicationDate\":{\"year\":\"2025\",\"month\":\"May\",\"day\":\"21\"}},\"publicationTypes\":[\"Journal Article\",\"Review\"],\"doi\":\"10.1016/j.euf.2025.05.006\",\"articleDates\":[{\"dateType\":\"Electronic\",\"year\":\"2025\",\"month\":\"5\",\"day\":\"21\"}]},{\"pmid\":\"40406639\",\"title\":\"Multidisciplinary Team Care: Adolescent Breast.\",\"abstractText\":\"Poland syndrome, tuberous breast deformity, gynecomastia, and macromastia are among the most common breast disorders affecting adolescents. While the etiology and physical manifestations may differ between each condition, they all may impose psychosocial stress necessitating evaluation and treatment. A multidisciplinary team is essential to providing comprehensive care specific to an adolescent population. The purpose of this chapter is to discuss common adolescent breast deformities necessitating plastic surgeon involvement, and the components of a successful multidisciplinary adolescent breast care team.\",\"authors\":[{\"lastName\":\"Mohan\",\"firstName\":\"Vamsi C\",\"initials\":\"VC\",\"affiliation\":\"Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.\"},{\"lastName\":\"Wang\",\"firstName\":\"Daniel S\",\"initials\":\"DS\",\"affiliation\":\"Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.\"},{\"lastName\":\"Skochdopole\",\"firstName\":\"Anna J\",\"initials\":\"AJ\",\"affiliation\":\"Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.\"},{\"lastName\":\"Dvoracek\",\"firstName\":\"Lucas A\",\"initials\":\"LA\",\"affiliation\":\"Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.\"}],\"journalInfo\":{\"title\":\"Seminars in plastic surgery\",\"isoAbbreviation\":\"Semin Plast Surg\",\"volume\":\"39\",\"issue\":\"2\",\"pages\":\"89-96\",\"publicationDate\":{\"year\":\"2025\",\"month\":\"May\"}},\"publicationTypes\":[\"Journal Article\",\"Review\"],\"doi\":\"10.1055/s-0045-1806807\",\"articleDates\":[{\"dateType\":\"Electronic\",\"year\":\"2025\",\"month\":\"3\",\"day\":\"31\"}]},{\"pmid\":\"40388094\",\"title\":\"Dermatologic diseases of the breast, areola and nipple.\",\"abstractText\":\"The range of dermatologic diseases of the breast, nipple, and areola (BNA) skin comprises various inflammatory and neoplastic alterations. BNA skin represents a unique functional unit with considerable emotional, sexual, and cosmetic importance. A specialized approach and adequate sensitivity are required for the diagnosis and treatment of dermatologic diseases in this area. This article reviews the normal anatomy of the breast, common inflammatory, infectious, and benign or malignant proliferative diseases or harmatomas that can present in the breast and nipple skin. Skin diseases in the breast area may be specific to this location or not, and can be classified into proliferative diseases, including malformations and neoplasms, and inflammatory diseases, which encompass both infectious and non-infectious inflammations. Benign proliferations include nipple adenoma, fibrous papules, seborrheic keratoses, gynecomastia, benign subcutaneous tumors, melanocytic and epidermal nevi. Malignant neoformations comprise Paget's disease, invasive breast cancer, inflammatory breast cancer, metastases, melanoma, and non-melanoma skin cancers including Merkel cell carcinoma, but also sarcomas. Inflammatory conditions are atopic, irritant, or allergic nipple eczema, radiation dermatitis, mastopathy and Koebner reactions of other skin diseases due to friction in this area. Infections include bacterial, fungal, and viral entities that might be typical for this area such as borrelial lymphocytoma.\",\"authors\":[{\"lastName\":\"Deluca\",\"firstName\":\"Jenny\",\"initials\":\"J\",\"affiliation\":\"Academic Teaching Department of Dermatology Venereology and Allergology, Central Hospital Bolzano-Bozen, Italy.\"},{\"lastName\":\"Pichler\",\"firstName\":\"Maria\",\"initials\":\"M\",\"affiliation\":\"Academic Teaching Department of Dermatology Venereology and Allergology, Central Hospital Bolzano-Bozen, Italy.\"},{\"lastName\":\"Bataraga\",\"firstName\":\"Elga\",\"initials\":\"E\",\"affiliation\":\"Department of Dermatology and Venereology, R&#x12b;ga Stradi&#x146;&#x161; University, R&#x12b;ga, Latvia.\"},{\"lastName\":\"Puviani\",\"firstName\":\"Mario\",\"initials\":\"M\",\"affiliation\":\"Italian Society of Dermatologic and Oncologic Surgery (SIDCO), Siena, Italy.\"},{\"lastName\":\"Eisendle\",\"firstName\":\"Klaus\",\"initials\":\"K\",\"affiliation\":\"Academic Teaching Department of Dermatology Venereology and Allergology, Central Hospital Bolzano-Bozen, Italy.\"}],\"journalInfo\":{\"title\":\"Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG\",\"isoAbbreviation\":\"J Dtsch Dermatol Ges\",\"volume\":\"23\",\"issue\":\"5\",\"pages\":\"621-641\",\"publicationDate\":{\"year\":\"2025\",\"month\":\"May\"}},\"publicationTypes\":[\"Journal Article\",\"Review\"],\"doi\":\"10.1111/ddg.15535\",\"meshTerms\":[{\"descriptorName\":\"Humans\",\"descriptorUi\":\"D006801\",\"isMajorTopic\":false},{\"descriptorName\":\"Breast Diseases\",\"descriptorUi\":\"D001941\",\"qualifierName\":\"diagnosis\",\"qualifierUi\":\"Q000175\",\"isMajorTopic\":true},{\"descriptorName\":\"Nipples\",\"descriptorUi\":\"D009558\",\"qualifierName\":\"pathology\",\"qualifierUi\":\"Q000473\",\"isMajorTopic\":true},{\"descriptorName\":\"Skin Diseases\",\"descriptorUi\":\"D012871\",\"qualifierName\":\"diagnosis\",\"qualifierUi\":\"Q000175\",\"isMajorTopic\":true}]},{\"pmid\":\"40304653\",\"title\":\"Tremor Associated With Klinefelter Syndrome: Report of a Case Treated by Deep Brain Stimulation and Systematic Review of the Literature.\",\"abstractText\":\"INTRODUCTION: Klinefelter syndrome (KS) is a sex chromosome-related genetic disease that commonly affects male subjects with infertility. Small testes, gynecomastia, infertility, and possible developmental abnormalities are symptoms of this condition. According to recent studies, people with KS also may have other neurologic problems, particularly tremors resembling essential tremors. Our review attempts to explore the features of tremors and their treatment in individuals with KS using case studies and previously published research.\\n\\nMATERIALS AND METHODS: A PubMed/Medline search was conducted according to the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines using the following MeSH terms: (\\\"Tremor\\\") AND (\\\"Klinefelter syndrome\\\") OR (\\\"Tremor\\\") AND (\\\"associated\\\") AND (\\\"Klinefelter syndrome\\\") OR (\\\"Tremor\\\") AND (\\\"hypogonadism\\\"). The review included 24 articles.\\n\\nRESULTS: The average age at tremor onset was 15.59 years, and the most prevalent tremor types (31.91% of cases) were a combination of postural and kinetic/intention tremors. Overall, 40% of patients exhibited some improvement; 10% showed significant improvement, and 50% showed no impact when antitremor medications were administered. Testosterone replacement therapy is not a suitable option for this symptom because the effects of testosterone treatment on tremors are inconsistent. In each of the three described cases, tremors were significantly relieved after deep brain stimulation (DBS) surgery of the ventral intermediate nucleus (VIM). We also report a case of a man aged 54 years with KS who was unable to perform his regular tasks owing to severe tremors. His tremor was well managed with bilateral DBS of the thalamic VIM nucleus.\\n\\nCONCLUSION: Tremors are a potentially disabling associated manifestation of KS. The available literature on the management of tremors in patients with KS is limited. Surgical VIM-DBS has shown promising results in managing medication-refractory tremors in patients with KS, with an acceptable safety profile. Further research is needed to determine the causes of tremors in KS and to optimize treatment.\",\"authors\":[{\"lastName\":\"Dabboucy\",\"firstName\":\"Baraa\",\"initials\":\"B\",\"affiliation\":\"Division of Neurosurgery (CHU de Qu&#xe9;bec-Universit&#xe9; Laval)-Axe Neurosciences, Department of Surgery, Qu&#xe9;bec City, Qu&#xe9;bec, Canada. Electronic address: baraa.dabboucy@gmail.com.\"},{\"lastName\":\"Hazrati\",\"firstName\":\"Reza\",\"initials\":\"R\",\"affiliation\":\"Division of Neurosurgery (CHU de Qu&#xe9;bec-Universit&#xe9; Laval)-Axe Neurosciences, Department of Surgery, Qu&#xe9;bec City, Qu&#xe9;bec, Canada.\"},{\"lastName\":\"Langlois\",\"firstName\":\"Melanie\",\"initials\":\"M\",\"affiliation\":\"CHU de Qu&#xe9;bec Research Center (CRCHU), Qu&#xe9;bec, Qu&#xe9;bec, Canada.\"},{\"lastName\":\"Prudhomme\",\"firstName\":\"Michel\",\"initials\":\"M\",\"affiliation\":\"Division of Neurosurgery (CHU de Qu&#xe9;bec-Universit&#xe9; Laval)-Axe Neurosciences, Department of Surgery, Qu&#xe9;bec City, Qu&#xe9;bec, Canada.\"}],\"journalInfo\":{\"title\":\"Neuromodulation : journal of the International Neuromodulation Society\",\"isoAbbreviation\":\"Neuromodulation\",\"volume\":\"\",\"issue\":\"\",\"pages\":\"\",\"publicationDate\":{\"year\":\"2025\",\"month\":\"Apr\",\"day\":\"30\"}},\"publicationTypes\":[\"Journal Article\",\"Review\"],\"doi\":\"10.1016/j.neurom.2025.03.073\",\"articleDates\":[{\"dateType\":\"Electronic\",\"year\":\"2025\",\"month\":\"4\",\"day\":\"30\"}]},{\"pmid\":\"39909181\",\"title\":\"Gynecomastia and its potential progression to male breast cancer: Mechanisms, genetic factors, and hormonal interactions.\",\"abstractText\":\"Gynecomastia is the most common breast condition in men, while male breast cancer remains relatively rare. This review explores the potential relationship between gynecomastia and male breast cancer, with a focus on the roles of hormonal imbalances, genetic factors, and molecular mechanisms in the progression of these conditions. While it remains controversial whether gynecomastia is a precancerous lesion for male breast cancer, this review summarizes the roles of estrogen and androgen receptors, the regulation of aromatase expression, and mutations in key genes such as BRCA1/2. These insights point to possible pathways by which gynecomastia could transition into male breast cancer. Additionally, hormones such as prolactin, insulin-like growth factor-1, and leptin may play significant roles in this progression. We provide an overview of the current understanding and identify key areas for further research, emphasizing the need for large-scale prospective studies to determine the causal relationship between gynecomastia and male breast cancer.\",\"authors\":[{\"lastName\":\"Fu\",\"firstName\":\"Dingyi\",\"initials\":\"D\",\"affiliation\":\"Breast Disease Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China; Nanjing Medical University, Nanjing 211166, China.\"},{\"lastName\":\"Miao\",\"firstName\":\"Haoquan\",\"initials\":\"H\",\"affiliation\":\"Breast Disease Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China; Nanjing Medical University, Nanjing 211166, China.\"},{\"lastName\":\"Wang\",\"firstName\":\"Zhonglin\",\"initials\":\"Z\",\"affiliation\":\"Department of General Surgery, The Second People's Hospital of Lianyungang, Lianyungang 222006, China.\"},{\"lastName\":\"Yang\",\"firstName\":\"Chuang\",\"initials\":\"C\",\"affiliation\":\"Breast Disease Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. Electronic address: yang@njmu.edu.cn.\"}],\"journalInfo\":{\"title\":\"Critical reviews in oncology/hematology\",\"isoAbbreviation\":\"Crit Rev Oncol Hematol\",\"volume\":\"208\",\"issue\":\"\",\"pages\":\"104651\",\"publicationDate\":{\"year\":\"2025\",\"month\":\"Apr\"}},\"publicationTypes\":[\"Journal Article\",\"Review\"],\"doi\":\"10.1016/j.critrevonc.2025.104651\",\"articleDates\":[{\"dateType\":\"Electronic\",\"year\":\"2025\",\"month\":\"2\",\"day\":\"3\"}],\"meshTerms\":[{\"descriptorName\":\"Humans\",\"descriptorUi\":\"D006801\",\"isMajorTopic\":false},{\"descriptorName\":\"Gynecomastia\",\"descriptorUi\":\"D006177\",\"qualifierName\":\"genetics\",\"qualifierUi\":\"Q000235\",\"isMajorTopic\":true},{\"descriptorName\":\"Male\",\"descriptorUi\":\"D008297\",\"isMajorTopic\":false},{\"descriptorName\":\"Breast Neoplasms, Male\",\"descriptorUi\":\"D018567\",\"qualifierName\":\"genetics\",\"qualifierUi\":\"Q000235\",\"isMajorTopic\":true},{\"descriptorName\":\"Receptors, Estrogen\",\"descriptorUi\":\"D011960\",\"qualifierName\":\"metabolism\",\"qualifierUi\":\"Q000378\",\"isMajorTopic\":false},{\"descriptorName\":\"Disease Progression\",\"descriptorUi\":\"D018450\",\"isMajorTopic\":false},{\"descriptorName\":\"Aromatase\",\"descriptorUi\":\"D001141\",\"qualifierName\":\"metabolism\",\"qualifierUi\":\"Q000378\",\"isMajorTopic\":false},{\"descriptorName\":\"Receptors, Androgen\",\"descriptorUi\":\"D011944\",\"qualifierName\":\"metabolism\",\"qualifierUi\":\"Q000378\",\"isMajorTopic\":false},{\"descriptorName\":\"Mutation\",\"descriptorUi\":\"D009154\",\"isMajorTopic\":false},{\"descriptorName\":\"BRCA1 Protein\",\"descriptorUi\":\"D019313\",\"qualifierName\":\"genetics\",\"qualifierUi\":\"Q000235\",\"isMajorTopic\":false}]},{\"pmid\":\"39935942\",\"title\":\"Incidence, Management, and Prevention of Gynecomastia and Breast Pain in Patients with Prostate Cancer Undergoing Antiandrogen Therapy: A Systematic Review and Meta-analysis of Randomized Controlled Trials.\",\"abstractText\":\"BACKGROUND AND OBJECTIVE: In patients with prostate cancer treated with antiandrogen monotherapy, gynecomastia and breast pain are relatively common. In the setting of androgen receptor pathway inhibitors (ARPIs), the incidence of these adverse events (AEs) remains unclear. In addition, the effect of prophylactic treatment on gynecomastia remains uncertain. We aimed to evaluate the incidence of gynecomastia and breast pain in prostate cancer patients treated with ARPIs compared with androgen deprivation therapy (ADT) and the effect of prophylactic treatment for these AEs due to antiandrogen therapy.\\n\\nMETHODS: In June 2024, we queried four databases-PubMed, Scopus, Web of Science, and Embase-for randomized controlled trials (RCTs) investigating prostate cancer treatments involving antiandrogen therapy. The endpoints of interest were the incidence of these AEs due to ARPIs and the effect of prophylactic treatment for these.\\n\\nKEY FINDINGS AND LIMITATIONS: Eighteen RCTs, comprising 5036 patients, were included in the systematic review and meta-analysis. ARPIs included enzalutamide, darolutamide, and apalutamide. The results indicated that patients who received ARPI monotherapy had a significantly higher incidence of gynecomastia than those who received ADT monotherapy (risk ratio [RR]: 5.19, 95% confidence interval [CI]: 3.58-7.51,&#xa0;<&#xa0;0.001). There was no significant difference in the incidence of gynecomastia between ARPI plus ADT therapy and ADT monotherapy (RR: 1.27, 95% CI: 0.84-1.93,&#xa0;=&#xa0;0.2). Prophylactic tamoxifen or radiotherapy reduced significantly the incidence of gynecomastia and breast pain caused by bicalutamide monotherapy.\\n\\nCONCLUSIONS AND CLINICAL IMPLICATIONS: We found that ARPI monotherapy increases the incidence of these AEs significantly compared with ADT. In contrast, ARPI plus ADT therapy did not result in a higher incidence of AEs. The use of either tamoxifen or radiotherapy was effective in reducing the incidence of these AEs due to bicalutamide monotherapy. These prophylactic treatments could reduce the incidence of AEs due to ARPI monotherapy. However, further studies are needed to clarify their efficacy.\\n\\nPATIENT SUMMARY: Although androgen deprivation therapy (ADT) improves overall survival in patients with prostate cancer, it is associated with several complications. Androgen receptor pathway inhibitor (ARPI) monotherapy has emerged as a promising strategy for improving oncological outcomes in these patients. However, ARPI monotherapy increases gynecomastia and breast pain in prostate cancer patients compared with ADT, while ARPI plus ADT did not result in a higher incidence of adverse events.\",\"authors\":[{\"lastName\":\"Tsuboi\",\"firstName\":\"Ichiro\",\"initials\":\"I\",\"affiliation\":\"Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.\"},{\"lastName\":\"Schulz\",\"firstName\":\"Robert J\",\"initials\":\"RJ\",\"affiliation\":\"Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.\"},{\"lastName\":\"Laukhtina\",\"firstName\":\"Ekaterina\",\"initials\":\"E\",\"affiliation\":\"Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.\"},{\"lastName\":\"Wada\",\"firstName\":\"Koichiro\",\"initials\":\"K\",\"affiliation\":\"Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.\"},{\"lastName\":\"Karakiewicz\",\"firstName\":\"Pierre I\",\"initials\":\"PI\",\"affiliation\":\"Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Quebec, Canada.\"},{\"lastName\":\"Araki\",\"firstName\":\"Motoo\",\"initials\":\"M\",\"affiliation\":\"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.\"},{\"lastName\":\"Shariat\",\"firstName\":\"Shahrokh F\",\"initials\":\"SF\",\"affiliation\":\"Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.\"}],\"journalInfo\":{\"title\":\"European urology open science\",\"isoAbbreviation\":\"Eur Urol Open Sci\",\"volume\":\"73\",\"issue\":\"\",\"pages\":\"31-42\",\"publicationDate\":{\"year\":\"2025\",\"month\":\"Mar\"}},\"publicationTypes\":[\"Journal Article\",\"Review\"],\"doi\":\"10.1016/j.euros.2025.01.001\",\"articleDates\":[{\"dateType\":\"Electronic\",\"year\":\"2025\",\"month\":\"1\",\"day\":\"27\"}]}],\"notFoundPmids\":[],\"eFetchDetails\":{\"urls\":[\"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=41263895%2C40913704%2C40331995%2C40561872%2C40404535%2C40406639%2C40388094%2C40304653%2C39909181%2C39935942&retmode=xml\"]}}"}],"isError":false}}}],"role":"user"}
-----------------------------------------------------------
Functions:
pubmed_article_connections: {'sourcePmid': {'description': 'The PubMed Unique Identifier (PMID) of the source article for which to find connections or format citations. This PMID must be a valid number string.', 'pattern': '^\\d+$', 'type': <Type.STRING: 'STRING'>}, 'relationshipType': {'default': 'pubmed_similar_articles', 'description': "Specifies the type of connection or action: 'pubmed_similar_articles' (finds similar articles), 'pubmed_citedin' (finds citing articles), 'pubmed_references' (finds referenced articles), or 'citation_formats' (retrieves formatted citations).", 'enum': ['pubmed_similar_articles', 'pubmed_citedin', 'pubmed_references', 'citation_formats'], 'type': <Type.STRING: 'STRING'>}, 'maxRelatedResults': {'default': 5, 'description': 'Maximum number of related articles to retrieve for relationship-based searches. Default is 5, max is 50.', 'maximum': 50.0, 'type': <Type.INTEGER: 'INTEGER'>}, 'citationStyles': {'default': ['ris'], 'description': "An array of citation styles to format the source article into when 'relationshipType' is 'citation_formats'. Supported styles: 'ris', 'bibtex', 'apa_string', 'mla_string'. Default is ['ris'].", 'items': {'enum': ['ris', 'bibtex', 'apa_string', 'mla_string'], 'type': <Type.STRING: 'STRING'>}, 'type': <Type.ARRAY: 'ARRAY'>}} 
pubmed_fetch_contents: {'pmids': {'description': 'An array of PubMed Unique Identifiers (PMIDs) to fetch. Use this OR queryKey/webEnv.', 'items': {'pattern': '^\\d+$', 'type': <Type.STRING: 'STRING'>}, 'max_items': 200, 'type': <Type.ARRAY: 'ARRAY'>}, 'queryKey': {'description': 'Query key from ESearch history. Requires webEnv. Use this OR pmids.', 'type': <Type.STRING: 'STRING'>}, 'webEnv': {'description': 'Web environment from ESearch history. Requires queryKey. Use this OR pmids.', 'type': <Type.STRING: 'STRING'>}, 'retstart': {'description': '0-based index of the first record to retrieve. Used with queryKey/webEnv.', 'minimum': 0.0, 'type': <Type.INTEGER: 'INTEGER'>}, 'retmax': {'description': 'Maximum number of records to retrieve. Used with queryKey/webEnv.', 'minimum': 1.0, 'type': <Type.INTEGER: 'INTEGER'>}, 'detailLevel': {'default': 'abstract_plus', 'description': "Specifies the level of detail for the fetched content. Options: 'abstract_plus' (parsed details), 'full_xml' (raw PubMedArticle XML), 'medline_text' (MEDLINE format), 'citation_data' (minimal citation data). Defaults to 'abstract_plus'.", 'enum': ['abstract_plus', 'full_xml', 'medline_text', 'citation_data'], 'type': <Type.STRING: 'STRING'>}, 'includeMeshTerms': {'default': True, 'description': "Include MeSH terms in 'abstract_plus' and 'citation_data' results. Default: true.", 'type': <Type.BOOLEAN: 'BOOLEAN'>}, 'includeGrantInfo': {'default': False, 'description': "Include grant info in 'abstract_plus' results. Default: false.", 'type': <Type.BOOLEAN: 'BOOLEAN'>}, 'outputFormat': {'default': 'json', 'description': "Output format. 'json' (default) wraps data in a JSON object. 'raw_text' returns raw text for 'medline_text' or 'full_xml' detail levels.", 'enum': ['json', 'raw_text'], 'type': <Type.STRING: 'STRING'>}} 
pubmed_generate_chart: {'chartType': {'description': 'Specifies the type of chart to generate.', 'enum': ['bar', 'line', 'scatter', 'pie', 'doughnut', 'bubble', 'radar', 'polarArea'], 'type': <Type.STRING: 'STRING'>}, 'title': {'description': 'The main title displayed above the chart.', 'type': <Type.STRING: 'STRING'>}, 'width': {'default': 800, 'description': 'The width of the chart canvas in pixels.', 'type': <Type.INTEGER: 'INTEGER'>}, 'height': {'default': 600, 'description': 'The height of the chart canvas in pixels.', 'type': <Type.INTEGER: 'INTEGER'>}, 'dataValues': {'description': "An array of data objects to plot the chart (e.g., [{ 'year': '2020', 'articles': 150 }]).", 'items': {'type': <Type.OBJECT: 'OBJECT'>}, 'min_items': 1, 'type': <Type.ARRAY: 'ARRAY'>}, 'outputFormat': {'default': 'png', 'description': 'Specifies the output format for the chart.', 'enum': ['png'], 'type': <Type.STRING: 'STRING'>}, 'xField': {'description': 'The field name from `dataValues` for the X-axis.', 'type': <Type.STRING: 'STRING'>}, 'yField': {'description': 'The field name from `dataValues` for the Y-axis.', 'type': <Type.STRING: 'STRING'>}, 'seriesField': {'description': 'The field name for creating multiple data series on the same chart.', 'type': <Type.STRING: 'STRING'>}, 'sizeField': {'description': 'For bubble charts, the field name for encoding bubble size.', 'type': <Type.STRING: 'STRING'>}} 
pubmed_research_agent: {'project_title_suggestion': {'description': 'A concise and descriptive title for the research project.', 'min_length': 5, 'type': <Type.STRING: 'STRING'>}, 'primary_research_goal': {'description': 'The main scientific objective or central question the research aims to address (e.g., "To investigate the role of TREM2 in microglial response to amyloid-beta plaques").', 'min_length': 10, 'type': <Type.STRING: 'STRING'>}, 'research_keywords': {'description': 'Core scientific keywords or MeSH terms defining the research domain (e.g., ["neuroinflammation", "Alzheimer\'s disease", "TREM2"]).', 'items': {'min_length': 1, 'type': <Type.STRING: 'STRING'>}, 'min_items': 1, 'type': <Type.ARRAY: 'ARRAY'>}, 'organism_focus': {'description': 'Primary organism(s) or model systems (e.g., "Homo sapiens (iPSC-derived microglia)", "Mus musculus (5xFAD model)").', 'type': <Type.STRING: 'STRING'>}, 'p1_introduction_and_background': {'description': 'Brief overview of the research area, its significance, and relevant background information leading to this study.', 'type': <Type.STRING: 'STRING'>}, 'p1_specific_research_question': {'description': 'The precise, focused primary research question the study will answer.', 'type': <Type.STRING: 'STRING'>}, 'p1_knowledge_gap': {'description': 'Statement clearly identifying the specific gap in current knowledge this research addresses.', 'type': <Type.STRING: 'STRING'>}, 'p1_primary_hypothesis': {'description': 'The main, testable hypothesis. Should be clear, specific, and falsifiable.', 'type': <Type.STRING: 'STRING'>}, 'p1_secondary_questions_or_hypotheses': {'description': 'Any secondary questions or hypotheses to be explored.', 'items': {'type': <Type.STRING: 'STRING'>}, 'type': <Type.ARRAY: 'ARRAY'>}, 'p1_pubmed_search_strategy_description': {'description': 'Description of the primary literature search strategy (e.g., for PubMed), including key terms and database considerations.', 'type': <Type.STRING: 'STRING'>}, 'p1_literature_review_scope': {'description': 'The defined scope for the literature review (e.g., timeframes, study types, key themes).', 'type': <Type.STRING: 'STRING'>}, 'p1_lit_review_databases_and_approach': {'description': 'Key databases (e.g., PubMed, EMBASE) and the search approach (e.g., iterative queries, snowballing).', 'type': <Type.STRING: 'STRING'>}, 'p1_experimental_paradigm': {'description': "The overarching experimental design or study type (e.g., 'comparative multi-omics analysis', 'longitudinal cohort study').", 'type': <Type.STRING: 'STRING'>}, 'p1_data_acquisition_plan_existing_data': {'description': 'Strategy for identifying and retrieving relevant existing datasets (databases, data types, tools).', 'type': <Type.STRING: 'STRING'>}, 'p1_data_acquisition_plan_new_data': {'description': 'Plan for generating novel data (data types, experimental models, key procedures, deposition plan).', 'type': <Type.STRING: 'STRING'>}, 'p1_blast_utilization_plan': {'description': 'If applicable, how sequence alignment services (e.g., NCBI BLAST) will be used (purpose, programs, databases).', 'type': <Type.STRING: 'STRING'>}, 'p1_controls_and_rigor': {'description': 'Description of key experimental controls and measures to ensure scientific rigor and reproducibility.', 'type': <Type.STRING: 'STRING'>}, 'p1_methodological_challenges_and_mitigation': {'description': 'Anticipated methodological challenges and proposed mitigation strategies.', 'type': <Type.STRING: 'STRING'>}, 'p2_data_collection_methods_wet_lab': {'description': 'Specific wet-lab protocols if new data is generated (sample prep, treatments, instruments).', 'type': <Type.STRING: 'STRING'>}, 'p2_data_collection_methods_dry_lab': {'description': 'Execution details for data retrieval from databases (queries, tools, accessioning).', 'type': <Type.STRING: 'STRING'>}, 'p2_data_preprocessing_and_qc_plan': {'description': 'Pipeline for data cleaning, preprocessing (e.g., alignment, normalization), and quality control (metrics, thresholds, tools).', 'type': <Type.STRING: 'STRING'>}, 'p3_data_analysis_strategy': {'description': 'Core statistical and computational methods to analyze data and test hypotheses (tests, software, ML models if any).', 'type': <Type.STRING: 'STRING'>}, 'p3_bioinformatics_pipeline_summary': {'description': 'Summary of the bioinformatics pipeline for high-throughput data analysis (tools, downstream analyses).', 'type': <Type.STRING: 'STRING'>}, 'p3_results_interpretation_framework': {'description': 'Framework for evaluating findings against hypotheses (statistical significance, biological relevance).', 'type': <Type.STRING: 'STRING'>}, 'p3_comparison_with_literature_plan': {'description': 'Strategy for contextualizing results with existing literature and addressing discrepancies.', 'type': <Type.STRING: 'STRING'>}, 'p4_dissemination_manuscript_plan': {'description': 'Plan for manuscript preparation (core message, target journal profile, key figures).', 'type': <Type.STRING: 'STRING'>}, 'p4_dissemination_data_deposition_plan': {'description': 'Strategy for depositing data in public repositories (types, repositories, FAIR principles).', 'type': <Type.STRING: 'STRING'>}, 'p4_peer_review_and_publication_approach': {'description': 'Approach to journal submission and addressing peer review.', 'type': <Type.STRING: 'STRING'>}, 'p4_future_research_directions': {'description': 'Potential next steps, new questions, or translational applications arising from the research.', 'type': <Type.STRING: 'STRING'>}, 'cc_record_keeping_and_data_management': {'description': 'Plan for record-keeping, version control, data storage, and DMP.', 'type': <Type.STRING: 'STRING'>}, 'cc_collaboration_strategy': {'description': 'If applicable, strategy for collaboration, communication, roles, and authorship.', 'type': <Type.STRING: 'STRING'>}, 'cc_ethical_considerations': {'description': 'Ethical considerations, IRB/IACUC approval plans, data privacy, RCR training.', 'type': <Type.STRING: 'STRING'>}, 'include_detailed_prompts_for_agent': {'default': False, 'description': 'If true, the tool will add more detailed instructive prompts/guidance within the output fields for a research agent. If false (default), it will primarily structure the provided inputs with minimal additional prompting.', 'type': <Type.BOOLEAN: 'BOOLEAN'>}} 
pubmed_search_articles: {'queryTerm': {'description': 'The primary keyword or phrase to search for in PubMed. Must be at least 3 characters long.', 'min_length': 3, 'type': <Type.STRING: 'STRING'>}, 'maxResults': {'default': 20, 'description': "Maximum number of articles to retrieve. Corresponds to ESearch's 'retmax' parameter. Default is 20, max is 1000.", 'maximum': 1000.0, 'type': <Type.INTEGER: 'INTEGER'>}, 'sortBy': {'default': 'relevance', 'description': "Sorting criteria for results. Options: 'relevance' (default), 'pub_date', 'author', 'journal_name'.", 'enum': ['relevance', 'pub_date', 'author', 'journal_name'], 'type': <Type.STRING: 'STRING'>}, 'dateRange': {'description': 'Defines an optional date range for the search.', 'properties': {'minDate': {'description': 'The start date for the search range (YYYY, YYYY/MM, or YYYY/MM/DD).', 'pattern': '^\\d{4}(\\/\\d{2}(\\/\\d{2})?)?$', 'type': <Type.STRING: 'STRING'>}, 'maxDate': {'description': 'The end date for the search range (YYYY, YYYY/MM, or YYYY/MM/DD).', 'pattern': '^\\d{4}(\\/\\d{2}(\\/\\d{2})?)?$', 'type': <Type.STRING: 'STRING'>}, 'dateType': {'default': 'pdat', 'description': "The type of date to filter by: 'pdat' (Publication Date), 'mdat' (Modification Date), 'edat' (Entrez Date). Default is 'pdat'.", 'enum': ['pdat', 'mdat', 'edat'], 'type': <Type.STRING: 'STRING'>}}, 'type': <Type.OBJECT: 'OBJECT'>}, 'filterByPublicationTypes': {'description': 'An array of publication types to filter by (e.g., ["Review", "Clinical Trial"]).', 'items': {'type': <Type.STRING: 'STRING'>}, 'type': <Type.ARRAY: 'ARRAY'>}, 'fetchBriefSummaries': {'default': 0, 'description': 'Number of top PMIDs for which to fetch brief summaries using ESummary. Set to 0 to disable. Max 50. Default 0.', 'maximum': 50.0, 'minimum': 0.0, 'type': <Type.INTEGER: 'INTEGER'>}} 
-----------------------------------------------------------

_trace.py:87 DEBUG:send_request_headers.started request=<Request [b'POST']>
_trace.py:87 DEBUG:send_request_headers.complete
_trace.py:87 DEBUG:send_request_body.started request=<Request [b'POST']>
_trace.py:87 DEBUG:send_request_body.complete
_trace.py:87 DEBUG:receive_response_headers.started request=<Request [b'POST']>
_trace.py:87 DEBUG:receive_response_headers.complete return_value=(b'HTTP/1.1', 200, b'OK', [(b'Content-Type', b'application/json; charset=UTF-8'), (b'Vary', b'Origin'), (b'Vary', b'X-Origin'), (b'Vary', b'Referer'), (b'Content-Encoding', b'gzip'), (b'Date', b'Mon, 01 Dec 2025 05:58:19 GMT'), (b'Server', b'scaffolding on HTTPServer2'), (b'X-XSS-Protection', b'0'), (b'X-Frame-Options', b'SAMEORIGIN'), (b'X-Content-Type-Options', b'nosniff'), (b'Server-Timing', b'gfet4t7; dur=7090'), (b'Alt-Svc', b'h3=":443"; ma=2592000,h3-29=":443"; ma=2592000'), (b'Transfer-Encoding', b'chunked')])
_client.py:1740 INFO:HTTP Request: POST https://generativelanguage.googleapis.com/v1beta/models/gemini-2.5-flash-lite:generateContent "HTTP/1.1 200 OK"
_trace.py:87 DEBUG:receive_response_body.started request=<Request [b'POST']>
_trace.py:87 DEBUG:receive_response_body.complete
_trace.py:87 DEBUG:response_closed.started
_trace.py:87 DEBUG:response_closed.complete
google_llm.py:186 INFO:Response received from the model.
google_llm.py:187 DEBUG:
LLM Response:
-----------------------------------------------------------
Text:
Here are the summaries of the research papers on Gynecomastia Surgery:

1.  **Title:** Content and Readability Analysis of Patient-Reported Outcome Measures for Gynecomastia: A Systematic Review.
    **Summary:** This systematic review identified 23 patient-reported outcome measures (PROMs) used for gynecomastia patients. While some PROMs adequately address appearance and self-perception, there are significant gaps in capturing the full spectrum of health-related quality of life and social outcomes. Additionally, the readability of most PROMs is too high for the general population, indicating a need for a more accessible gynecomastia-specific instrument.
    **Citation:** Vaile JR, Cordray H, Terry PH, et al. Content and Readability Analysis of Patient-Reported Outcome Measures for Gynecomastia: A Systematic Review. *Ann Plast Surg*. 2025;95(6):744-751. doi:10.1097/SAP.0000000000004482. [Link](https://pubmed.ncbi.nlm.nih.gov/41263895/)

2.  **Title:** Male breast MRI: a review of different pathological conditions.
    **Summary:** This review discusses the utility of MRI in diagnosing various male breast pathologies, including benign conditions like gynecomastia and malignant entities like male breast cancer. It emphasizes the distinctive features observed on MRI for these conditions and highlights MRI's potential role as a complementary tool to traditional imaging methods, particularly for evaluating pre- and post-surgical treatments.
    **Citation:** Barillari M, Zanutto P, Pellini F, et al. Male breast MRI: a review of different pathological conditions. *Radiol Med*. 2025;130(11):1752-1766. doi:10.1007/s11547-025-02084-x. [Link](https://pubmed.ncbi.nlm.nih.gov/40913704/)

3.  **Title:** Diseases of the Male Breast: Gynecomastia and Breast Cancer.
    **Summary:** This review focuses on the diagnosis and management of gynecomastia and male breast cancer. It outlines the physiological occurrences of gynecomastia and details the diagnostic workup, including history, physical examination, imaging, and laboratory tests. Treatment strategies for gynecomastia range from observation to pharmacotherapy and surgery, while the treatment for male breast cancer is analogous to that for female breast cancer.
    **Citation:** Faridi A, Gerber B, Hartmann S. Diseases of the Male Breast: Gynecomastia and Breast Cancer. *Dtsch Arztebl Int*. 2025;122(15):406-411. doi:10.3238/arztebl.m2025.0071. [Link](https://pubmed.ncbi.nlm.nih.gov/40331995/)

4.  **Title:** [Management strategies for gynecomastia in patients with prostate cancer treated with androgen receptor pathway inhibitors].
    **Summary:** This review evaluates the incidence, impact, and management of gynecomastia induced by hormonal therapy in prostate cancer patients, particularly those on androgen receptor pathway inhibitors (ARPIs). It discusses prophylactic and curative strategies, noting that tamoxifen and male breast radiotherapy are effective in preventing or treating gynecomastia. The review suggests that tamoxifen is more effective in the curative setting, but further studies are needed for ARPIs.
    **Citation:** Vibert N, Achard V, Pouvreau P, et al. [Management strategies for gynecomastia in patients with prostate cancer treated with androgen receptor pathway inhibitors]. *Cancer Radiother*. 2025;29(4):104665. doi:10.1016/j.canrad.2025.104665. [Link](https://pubmed.ncbi.nlm.nih.gov/40561872/)

5.  **Title:** Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life-A Systematic Review and Meta-analysis.
    **Summary:** This systematic review and meta-analysis compared the safety, efficacy, and quality of life of androgen receptor pathway inhibitor (ARPI) monotherapy with ARPI + androgen deprivation therapy (ADT) and ADT alone in prostate cancer patients. While overall adverse events were similar, ARPI monotherapy led to higher rates of grade 3 adverse events, including fatigue and cardiovascular toxicity. It also resulted in a higher incidence of breast pain and gynecomastia compared to ARPI + ADT.
    **Citation:** Fazekas T, Miszczyk M, Giesen A, et al. Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life-A Systematic Review and Meta-analysis. *Eur Urol Focus*. 2025;[Epub ahead of print]. doi:10.1016/j.euf.2025.05.006. [Link](https://pubmed.ncbi.nlm.nih.gov/40404535/)

6.  **Title:** Multidisciplinary Team Care: Adolescent Breast.
    **Summary:** This chapter discusses common breast disorders in adolescents, including Poland syndrome, tuberous breast deformity, gynecomastia, and macromastia, which can cause psychosocial stress. It emphasizes the importance of a multidisciplinary team approach for comprehensive care tailored to adolescents, highlighting the essential role of plastic surgeons.
    **Citation:** Mohan VC, Wang DS, Skochdopole AJ, Dvoracek LA. Multidisciplinary Team Care: Adolescent Breast. *Semin Plast Surg*. 2025;39(2):89-96. doi:10.1055/s-0045-1806807. [Link](https://pubmed.ncbi.nlm.nih.gov/40406639/)

7.  **Title:** Dermatologic diseases of the breast, areola and nipple.
    **Summary:** This review covers a range of dermatologic conditions affecting the breast, nipple, and areola (BNA) skin, including inflammatory and neoplastic alterations. It classifies benign proliferations such as gynecomastia and malignant neoformations, as well as inflammatory conditions and infections specific to this area. The article stresses the need for a specialized approach to diagnose and treat dermatologic diseases in the BNA region.
    **Citation:** Deluca J, Pichler M, Bataraga E, Puviani M, Eisendle K. Dermatologic diseases of the breast, areola and nipple. *J Dtsch Dermatol Ges*. 2025;23(5):621-641. doi:10.1111/ddg.15535. [Link](https://pubmed.ncbi.nlm.nih.gov/40388094/)

8.  **Title:** Tremor Associated With Klinefelter Syndrome: Report of a Case Treated by Deep Brain Stimulation and Systematic Review of the Literature.
    **Summary:** This study reviews tremors associated with Klinefelter syndrome (KS), noting that tremors are a disabling manifestation of the condition. While conventional antitremor medications have inconsistent effects, deep brain stimulation (DBS) of the ventral intermediate nucleus (VIM) has shown promising results in managing medication-refractory tremors in KS patients.
    **Citation:** Dabboucy B, Hazrati R, Langlois M, Prudhomme M. Tremor Associated With Klinefelter Syndrome: Report of a Case Treated by Deep Brain Stimulation and Systematic Review of the Literature. *Neuromodulation*. 2025;[Epub ahead of print]. doi:10.1016/j.neurom.2025.03.073. [Link](https://pubmed.ncbi.nlm.nih.gov/40304653/)

9.  **Title:** Gynecomastia and its potential progression to male breast cancer: Mechanisms, genetic factors, and hormonal interactions.
    **Summary:** This review explores the relationship between gynecomastia and male breast cancer, focusing on hormonal imbalances, genetic factors, and molecular mechanisms. It discusses the roles of estrogen and androgen receptors, aromatase expression, and mutations in genes like BRCA1/2. The review suggests that hormonal factors and specific gene mutations may contribute to the progression from gynecomastia to male breast cancer, highlighting the need for further research.
    **Citation:** Fu D, Miao H, Wang Z, Yang C. Gynecomastia and its potential progression to male breast cancer: Mechanisms, genetic factors, and hormonal interactions. *Crit Rev Oncol Hematol*. 2025;208:104651. doi:10.1016/j.critrevonc.2025.104651. [Link](https://pubmed.ncbi.nlm.nih.gov/39909181/)

10. **Title:** Incidence, Management, and Prevention of Gynecomastia and Breast Pain in Patients with Prostate Cancer Undergoing Antiandrogen Therapy: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    **Summary:** This systematic review and meta-analysis found that androgen receptor pathway inhibitor (ARPI) monotherapy in prostate cancer patients significantly increases the incidence of gynecomastia and breast pain compared to androgen deprivation therapy (ADT). However, combining ARPIs with ADT did not result in a higher incidence of these adverse events. Prophylactic tamoxifen or radiotherapy was effective in reducing gynecomastia and breast pain caused by bicalutamide.
    **Citation:** Tsuboi I, Schulz RJ, Laukhtina E, et al. Incidence, Management, and Prevention of Gynecomastia and Breast Pain in Patients with Prostate Cancer Undergoing Antiandrogen Therapy: A Systematic Review and Meta-analysis of Randomized Controlled Trials. *Eur Urol Open Sci*. 2025;73:31-42. doi:10.1016/j.euros.2025.01.001. [Link](https://pubmed.ncbi.nlm.nih.gov/39935942/)
-----------------------------------------------------------
Function calls:

-----------------------------------------------------------
Raw response:
{"sdk_http_response":{"headers":{"content-type":"application/json; charset=UTF-8","vary":"Origin, X-Origin, Referer","content-encoding":"gzip","date":"Mon, 01 Dec 2025 05:58:19 GMT","server":"scaffolding on HTTPServer2","x-xss-protection":"0","x-frame-options":"SAMEORIGIN","x-content-type-options":"nosniff","server-timing":"gfet4t7; dur=7090","alt-svc":"h3=\":443\"; ma=2592000,h3-29=\":443\"; ma=2592000","transfer-encoding":"chunked"}},"candidates":[{"content":{"parts":[{"text":"Here are the summaries of the research papers on Gynecomastia Surgery:\n\n1.  **Title:** Content and Readability Analysis of Patient-Reported Outcome Measures for Gynecomastia: A Systematic Review.\n    **Summary:** This systematic review identified 23 patient-reported outcome measures (PROMs) used for gynecomastia patients. While some PROMs adequately address appearance and self-perception, there are significant gaps in capturing the full spectrum of health-related quality of life and social outcomes. Additionally, the readability of most PROMs is too high for the general population, indicating a need for a more accessible gynecomastia-specific instrument.\n    **Citation:** Vaile JR, Cordray H, Terry PH, et al. Content and Readability Analysis of Patient-Reported Outcome Measures for Gynecomastia: A Systematic Review. *Ann Plast Surg*. 2025;95(6):744-751. doi:10.1097/SAP.0000000000004482. [Link](https://pubmed.ncbi.nlm.nih.gov/41263895/)\n\n2.  **Title:** Male breast MRI: a review of different pathological conditions.\n    **Summary:** This review discusses the utility of MRI in diagnosing various male breast pathologies, including benign conditions like gynecomastia and malignant entities like male breast cancer. It emphasizes the distinctive features observed on MRI for these conditions and highlights MRI's potential role as a complementary tool to traditional imaging methods, particularly for evaluating pre- and post-surgical treatments.\n    **Citation:** Barillari M, Zanutto P, Pellini F, et al. Male breast MRI: a review of different pathological conditions. *Radiol Med*. 2025;130(11):1752-1766. doi:10.1007/s11547-025-02084-x. [Link](https://pubmed.ncbi.nlm.nih.gov/40913704/)\n\n3.  **Title:** Diseases of the Male Breast: Gynecomastia and Breast Cancer.\n    **Summary:** This review focuses on the diagnosis and management of gynecomastia and male breast cancer. It outlines the physiological occurrences of gynecomastia and details the diagnostic workup, including history, physical examination, imaging, and laboratory tests. Treatment strategies for gynecomastia range from observation to pharmacotherapy and surgery, while the treatment for male breast cancer is analogous to that for female breast cancer.\n    **Citation:** Faridi A, Gerber B, Hartmann S. Diseases of the Male Breast: Gynecomastia and Breast Cancer. *Dtsch Arztebl Int*. 2025;122(15):406-411. doi:10.3238/arztebl.m2025.0071. [Link](https://pubmed.ncbi.nlm.nih.gov/40331995/)\n\n4.  **Title:** [Management strategies for gynecomastia in patients with prostate cancer treated with androgen receptor pathway inhibitors].\n    **Summary:** This review evaluates the incidence, impact, and management of gynecomastia induced by hormonal therapy in prostate cancer patients, particularly those on androgen receptor pathway inhibitors (ARPIs). It discusses prophylactic and curative strategies, noting that tamoxifen and male breast radiotherapy are effective in preventing or treating gynecomastia. The review suggests that tamoxifen is more effective in the curative setting, but further studies are needed for ARPIs.\n    **Citation:** Vibert N, Achard V, Pouvreau P, et al. [Management strategies for gynecomastia in patients with prostate cancer treated with androgen receptor pathway inhibitors]. *Cancer Radiother*. 2025;29(4):104665. doi:10.1016/j.canrad.2025.104665. [Link](https://pubmed.ncbi.nlm.nih.gov/40561872/)\n\n5.  **Title:** Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life-A Systematic Review and Meta-analysis.\n    **Summary:** This systematic review and meta-analysis compared the safety, efficacy, and quality of life of androgen receptor pathway inhibitor (ARPI) monotherapy with ARPI + androgen deprivation therapy (ADT) and ADT alone in prostate cancer patients. While overall adverse events were similar, ARPI monotherapy led to higher rates of grade 3 adverse events, including fatigue and cardiovascular toxicity. It also resulted in a higher incidence of breast pain and gynecomastia compared to ARPI + ADT.\n    **Citation:** Fazekas T, Miszczyk M, Giesen A, et al. Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life-A Systematic Review and Meta-analysis. *Eur Urol Focus*. 2025;[Epub ahead of print]. doi:10.1016/j.euf.2025.05.006. [Link](https://pubmed.ncbi.nlm.nih.gov/40404535/)\n\n6.  **Title:** Multidisciplinary Team Care: Adolescent Breast.\n    **Summary:** This chapter discusses common breast disorders in adolescents, including Poland syndrome, tuberous breast deformity, gynecomastia, and macromastia, which can cause psychosocial stress. It emphasizes the importance of a multidisciplinary team approach for comprehensive care tailored to adolescents, highlighting the essential role of plastic surgeons.\n    **Citation:** Mohan VC, Wang DS, Skochdopole AJ, Dvoracek LA. Multidisciplinary Team Care: Adolescent Breast. *Semin Plast Surg*. 2025;39(2):89-96. doi:10.1055/s-0045-1806807. [Link](https://pubmed.ncbi.nlm.nih.gov/40406639/)\n\n7.  **Title:** Dermatologic diseases of the breast, areola and nipple.\n    **Summary:** This review covers a range of dermatologic conditions affecting the breast, nipple, and areola (BNA) skin, including inflammatory and neoplastic alterations. It classifies benign proliferations such as gynecomastia and malignant neoformations, as well as inflammatory conditions and infections specific to this area. The article stresses the need for a specialized approach to diagnose and treat dermatologic diseases in the BNA region.\n    **Citation:** Deluca J, Pichler M, Bataraga E, Puviani M, Eisendle K. Dermatologic diseases of the breast, areola and nipple. *J Dtsch Dermatol Ges*. 2025;23(5):621-641. doi:10.1111/ddg.15535. [Link](https://pubmed.ncbi.nlm.nih.gov/40388094/)\n\n8.  **Title:** Tremor Associated With Klinefelter Syndrome: Report of a Case Treated by Deep Brain Stimulation and Systematic Review of the Literature.\n    **Summary:** This study reviews tremors associated with Klinefelter syndrome (KS), noting that tremors are a disabling manifestation of the condition. While conventional antitremor medications have inconsistent effects, deep brain stimulation (DBS) of the ventral intermediate nucleus (VIM) has shown promising results in managing medication-refractory tremors in KS patients.\n    **Citation:** Dabboucy B, Hazrati R, Langlois M, Prudhomme M. Tremor Associated With Klinefelter Syndrome: Report of a Case Treated by Deep Brain Stimulation and Systematic Review of the Literature. *Neuromodulation*. 2025;[Epub ahead of print]. doi:10.1016/j.neurom.2025.03.073. [Link](https://pubmed.ncbi.nlm.nih.gov/40304653/)\n\n9.  **Title:** Gynecomastia and its potential progression to male breast cancer: Mechanisms, genetic factors, and hormonal interactions.\n    **Summary:** This review explores the relationship between gynecomastia and male breast cancer, focusing on hormonal imbalances, genetic factors, and molecular mechanisms. It discusses the roles of estrogen and androgen receptors, aromatase expression, and mutations in genes like BRCA1/2. The review suggests that hormonal factors and specific gene mutations may contribute to the progression from gynecomastia to male breast cancer, highlighting the need for further research.\n    **Citation:** Fu D, Miao H, Wang Z, Yang C. Gynecomastia and its potential progression to male breast cancer: Mechanisms, genetic factors, and hormonal interactions. *Crit Rev Oncol Hematol*. 2025;208:104651. doi:10.1016/j.critrevonc.2025.104651. [Link](https://pubmed.ncbi.nlm.nih.gov/39909181/)\n\n10. **Title:** Incidence, Management, and Prevention of Gynecomastia and Breast Pain in Patients with Prostate Cancer Undergoing Antiandrogen Therapy: A Systematic Review and Meta-analysis of Randomized Controlled Trials.\n    **Summary:** This systematic review and meta-analysis found that androgen receptor pathway inhibitor (ARPI) monotherapy in prostate cancer patients significantly increases the incidence of gynecomastia and breast pain compared to androgen deprivation therapy (ADT). However, combining ARPIs with ADT did not result in a higher incidence of these adverse events. Prophylactic tamoxifen or radiotherapy was effective in reducing gynecomastia and breast pain caused by bicalutamide.\n    **Citation:** Tsuboi I, Schulz RJ, Laukhtina E, et al. Incidence, Management, and Prevention of Gynecomastia and Breast Pain in Patients with Prostate Cancer Undergoing Antiandrogen Therapy: A Systematic Review and Meta-analysis of Randomized Controlled Trials. *Eur Urol Open Sci*. 2025;73:31-42. doi:10.1016/j.euros.2025.01.001. [Link](https://pubmed.ncbi.nlm.nih.gov/39935942/)"}],"role":"model"},"finish_reason":"STOP","index":0}],"model_version":"gemini-2.5-flash-lite","response_id":"ey4tae-vB8WxjMcPj6r60Ag","usage_metadata":{"candidates_token_count":2254,"prompt_token_count":14773,"prompt_tokens_details":[{"modality":"TEXT","token_count":14773}],"total_token_count":17027}}
-----------------------------------------------------------

base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
base_authenticated_tool.py:72 DEBUG:auth_config or auth_config.auth_scheme is missing, so authentication will be skipped.
google_llm.py:133 INFO:Sending out request, model: gemini-2.5-flash-lite, backend: GoogleLLMVariant.GEMINI_API, stream: False
google_llm.py:139 DEBUG:
LLM Request:
-----------------------------------------------------------
System Instruction:
 You are an expert research assistant writing reports for the general public.
     
    For research requests: 
    1. Use `pubmed_search_agent` to find relevant research papers.  
    2. Use `summarize_agent` to summarize the papers found.
    3. Write a concise report. Your report MUST include the PMIDs returned from `pubmed_search_agent`.
    4. Always use the tools provided; never fabricate information or citations.
    

You are an agent. Your internal name is "research_paper_finder_agent".
-----------------------------------------------------------
Config:
{'tools': [{}]}
-----------------------------------------------------------
Contents:
{"parts":[{"text":"I want to know more about Gynecomastia Surgery."}],"role":"user"}
{"parts":[{"function_call":{"args":{"request":"Gynecomastia Surgery"},"name":"pubmed_search_agent"}}],"role":"model"}
{"parts":[{"function_response":{"name":"pubmed_search_agent","response":{"result":"Here are some relevant research papers on Gynecomastia Surgery: 41263895, 40913704, 40331995, 40561872, 40404535, 40406639, 40388094, 40304653, 39909181, 39935942."}}}],"role":"user"}
{"parts":[{"function_call":{"args":{"request":"Summarize the following papers about Gynecomastia Surgery: 41263895, 40913704, 40331995, 40561872, 40404535, 40406639, 40388094, 40304653, 39909181, 39935942."},"name":"summarize_agent"}}],"role":"model"}
{"parts":[{"function_response":{"name":"summarize_agent","response":{"result":"Here are the summaries of the research papers on Gynecomastia Surgery:\n\n1.  **Title:** Content and Readability Analysis of Patient-Reported Outcome Measures for Gynecomastia: A Systematic Review.\n    **Summary:** This systematic review identified 23 patient-reported outcome measures (PROMs) used for gynecomastia patients. While some PROMs adequately address appearance and self-perception, there are significant gaps in capturing the full spectrum of health-related quality of life and social outcomes. Additionally, the readability of most PROMs is too high for the general population, indicating a need for a more accessible gynecomastia-specific instrument.\n    **Citation:** Vaile JR, Cordray H, Terry PH, et al. Content and Readability Analysis of Patient-Reported Outcome Measures for Gynecomastia: A Systematic Review. *Ann Plast Surg*. 2025;95(6):744-751. doi:10.1097/SAP.0000000000004482. [Link](https://pubmed.ncbi.nlm.nih.gov/41263895/)\n\n2.  **Title:** Male breast MRI: a review of different pathological conditions.\n    **Summary:** This review discusses the utility of MRI in diagnosing various male breast pathologies, including benign conditions like gynecomastia and malignant entities like male breast cancer. It emphasizes the distinctive features observed on MRI for these conditions and highlights MRI's potential role as a complementary tool to traditional imaging methods, particularly for evaluating pre- and post-surgical treatments.\n    **Citation:** Barillari M, Zanutto P, Pellini F, et al. Male breast MRI: a review of different pathological conditions. *Radiol Med*. 2025;130(11):1752-1766. doi:10.1007/s11547-025-02084-x. [Link](https://pubmed.ncbi.nlm.nih.gov/40913704/)\n\n3.  **Title:** Diseases of the Male Breast: Gynecomastia and Breast Cancer.\n    **Summary:** This review focuses on the diagnosis and management of gynecomastia and male breast cancer. It outlines the physiological occurrences of gynecomastia and details the diagnostic workup, including history, physical examination, imaging, and laboratory tests. Treatment strategies for gynecomastia range from observation to pharmacotherapy and surgery, while the treatment for male breast cancer is analogous to that for female breast cancer.\n    **Citation:** Faridi A, Gerber B, Hartmann S. Diseases of the Male Breast: Gynecomastia and Breast Cancer. *Dtsch Arztebl Int*. 2025;122(15):406-411. doi:10.3238/arztebl.m2025.0071. [Link](https://pubmed.ncbi.nlm.nih.gov/40331995/)\n\n4.  **Title:** [Management strategies for gynecomastia in patients with prostate cancer treated with androgen receptor pathway inhibitors].\n    **Summary:** This review evaluates the incidence, impact, and management of gynecomastia induced by hormonal therapy in prostate cancer patients, particularly those on androgen receptor pathway inhibitors (ARPIs). It discusses prophylactic and curative strategies, noting that tamoxifen and male breast radiotherapy are effective in preventing or treating gynecomastia. The review suggests that tamoxifen is more effective in the curative setting, but further studies are needed for ARPIs.\n    **Citation:** Vibert N, Achard V, Pouvreau P, et al. [Management strategies for gynecomastia in patients with prostate cancer treated with androgen receptor pathway inhibitors]. *Cancer Radiother*. 2025;29(4):104665. doi:10.1016/j.canrad.2025.104665. [Link](https://pubmed.ncbi.nlm.nih.gov/40561872/)\n\n5.  **Title:** Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life-A Systematic Review and Meta-analysis.\n    **Summary:** This systematic review and meta-analysis compared the safety, efficacy, and quality of life of androgen receptor pathway inhibitor (ARPI) monotherapy with ARPI + androgen deprivation therapy (ADT) and ADT alone in prostate cancer patients. While overall adverse events were similar, ARPI monotherapy led to higher rates of grade 3 adverse events, including fatigue and cardiovascular toxicity. It also resulted in a higher incidence of breast pain and gynecomastia compared to ARPI + ADT.\n    **Citation:** Fazekas T, Miszczyk M, Giesen A, et al. Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life-A Systematic Review and Meta-analysis. *Eur Urol Focus*. 2025;[Epub ahead of print]. doi:10.1016/j.euf.2025.05.006. [Link](https://pubmed.ncbi.nlm.nih.gov/40404535/)\n\n6.  **Title:** Multidisciplinary Team Care: Adolescent Breast.\n    **Summary:** This chapter discusses common breast disorders in adolescents, including Poland syndrome, tuberous breast deformity, gynecomastia, and macromastia, which can cause psychosocial stress. It emphasizes the importance of a multidisciplinary team approach for comprehensive care tailored to adolescents, highlighting the essential role of plastic surgeons.\n    **Citation:** Mohan VC, Wang DS, Skochdopole AJ, Dvoracek LA. Multidisciplinary Team Care: Adolescent Breast. *Semin Plast Surg*. 2025;39(2):89-96. doi:10.1055/s-0045-1806807. [Link](https://pubmed.ncbi.nlm.nih.gov/40406639/)\n\n7.  **Title:** Dermatologic diseases of the breast, areola and nipple.\n    **Summary:** This review covers a range of dermatologic conditions affecting the breast, nipple, and areola (BNA) skin, including inflammatory and neoplastic alterations. It classifies benign proliferations such as gynecomastia and malignant neoformations, as well as inflammatory conditions and infections specific to this area. The article stresses the need for a specialized approach to diagnose and treat dermatologic diseases in the BNA region.\n    **Citation:** Deluca J, Pichler M, Bataraga E, Puviani M, Eisendle K. Dermatologic diseases of the breast, areola and nipple. *J Dtsch Dermatol Ges*. 2025;23(5):621-641. doi:10.1111/ddg.15535. [Link](https://pubmed.ncbi.nlm.nih.gov/40388094/)\n\n8.  **Title:** Tremor Associated With Klinefelter Syndrome: Report of a Case Treated by Deep Brain Stimulation and Systematic Review of the Literature.\n    **Summary:** This study reviews tremors associated with Klinefelter syndrome (KS), noting that tremors are a disabling manifestation of the condition. While conventional antitremor medications have inconsistent effects, deep brain stimulation (DBS) of the ventral intermediate nucleus (VIM) has shown promising results in managing medication-refractory tremors in KS patients.\n    **Citation:** Dabboucy B, Hazrati R, Langlois M, Prudhomme M. Tremor Associated With Klinefelter Syndrome: Report of a Case Treated by Deep Brain Stimulation and Systematic Review of the Literature. *Neuromodulation*. 2025;[Epub ahead of print]. doi:10.1016/j.neurom.2025.03.073. [Link](https://pubmed.ncbi.nlm.nih.gov/40304653/)\n\n9.  **Title:** Gynecomastia and its potential progression to male breast cancer: Mechanisms, genetic factors, and hormonal interactions.\n    **Summary:** This review explores the relationship between gynecomastia and male breast cancer, focusing on hormonal imbalances, genetic factors, and molecular mechanisms. It discusses the roles of estrogen and androgen receptors, aromatase expression, and mutations in genes like BRCA1/2. The review suggests that hormonal factors and specific gene mutations may contribute to the progression from gynecomastia to male breast cancer, highlighting the need for further research.\n    **Citation:** Fu D, Miao H, Wang Z, Yang C. Gynecomastia and its potential progression to male breast cancer: Mechanisms, genetic factors, and hormonal interactions. *Crit Rev Oncol Hematol*. 2025;208:104651. doi:10.1016/j.critrevonc.2025.104651. [Link](https://pubmed.ncbi.nlm.nih.gov/39909181/)\n\n10. **Title:** Incidence, Management, and Prevention of Gynecomastia and Breast Pain in Patients with Prostate Cancer Undergoing Antiandrogen Therapy: A Systematic Review and Meta-analysis of Randomized Controlled Trials.\n    **Summary:** This systematic review and meta-analysis found that androgen receptor pathway inhibitor (ARPI) monotherapy in prostate cancer patients significantly increases the incidence of gynecomastia and breast pain compared to androgen deprivation therapy (ADT). However, combining ARPIs with ADT did not result in a higher incidence of these adverse events. Prophylactic tamoxifen or radiotherapy was effective in reducing gynecomastia and breast pain caused by bicalutamide.\n    **Citation:** Tsuboi I, Schulz RJ, Laukhtina E, et al. Incidence, Management, and Prevention of Gynecomastia and Breast Pain in Patients with Prostate Cancer Undergoing Antiandrogen Therapy: A Systematic Review and Meta-analysis of Randomized Controlled Trials. *Eur Urol Open Sci*. 2025;73:31-42. doi:10.1016/j.euros.2025.01.001. [Link](https://pubmed.ncbi.nlm.nih.gov/39935942/)"}}}],"role":"user"}
-----------------------------------------------------------
Functions:
pubmed_search_agent: {'request': {'type': <Type.STRING: 'STRING'>}} 
summarize_agent: {'request': {'type': <Type.STRING: 'STRING'>}} 
-----------------------------------------------------------

_trace.py:87 DEBUG:close.started
_trace.py:87 DEBUG:close.complete
_trace.py:87 DEBUG:connect_tcp.started host='generativelanguage.googleapis.com' port=443 local_address=None timeout=None socket_options=None
_trace.py:87 DEBUG:connect_tcp.complete return_value=<httpcore._backends.anyio.AnyIOStream object at 0x112ffbd10>
_trace.py:87 DEBUG:start_tls.started ssl_context=<ssl.SSLContext object at 0x112ef6850> server_hostname='generativelanguage.googleapis.com' timeout=None
_trace.py:87 DEBUG:start_tls.complete return_value=<httpcore._backends.anyio.AnyIOStream object at 0x112ffaa50>
_trace.py:87 DEBUG:send_request_headers.started request=<Request [b'POST']>
_trace.py:87 DEBUG:send_request_headers.complete
_trace.py:87 DEBUG:send_request_body.started request=<Request [b'POST']>
_trace.py:87 DEBUG:send_request_body.complete
_trace.py:87 DEBUG:receive_response_headers.started request=<Request [b'POST']>
_trace.py:87 DEBUG:receive_response_headers.complete return_value=(b'HTTP/1.1', 200, b'OK', [(b'Content-Type', b'application/json; charset=UTF-8'), (b'Vary', b'Origin'), (b'Vary', b'X-Origin'), (b'Vary', b'Referer'), (b'Content-Encoding', b'gzip'), (b'Date', b'Mon, 01 Dec 2025 05:58:23 GMT'), (b'Server', b'scaffolding on HTTPServer2'), (b'X-XSS-Protection', b'0'), (b'X-Frame-Options', b'SAMEORIGIN'), (b'X-Content-Type-Options', b'nosniff'), (b'Server-Timing', b'gfet4t7; dur=4531'), (b'Alt-Svc', b'h3=":443"; ma=2592000,h3-29=":443"; ma=2592000'), (b'Transfer-Encoding', b'chunked')])
_client.py:1740 INFO:HTTP Request: POST https://generativelanguage.googleapis.com/v1beta/models/gemini-2.5-flash-lite:generateContent "HTTP/1.1 200 OK"
_trace.py:87 DEBUG:receive_response_body.started request=<Request [b'POST']>
_trace.py:87 DEBUG:receive_response_body.complete
_trace.py:87 DEBUG:response_closed.started
_trace.py:87 DEBUG:response_closed.complete
google_llm.py:186 INFO:Response received from the model.
google_llm.py:187 DEBUG:
LLM Response:
-----------------------------------------------------------
Text:
## Report: Understanding Gynecomastia Surgery

This report synthesizes findings from recent research on gynecomastia, a condition characterized by the enlargement of male breast tissue. The research highlights various aspects, including diagnostic tools, treatment strategies, and the impact of gynecomastia on patients' quality of life.

**Key Findings:**

*   **Diagnostic Challenges and Patient-Reported Outcomes:** A systematic review (PMID: 41263895) found that while existing patient-reported outcome measures (PROMs) capture some aspects of gynecomastia, there are significant gaps in assessing the full spectrum of quality of life impacts. Furthermore, the readability of many PROMs is too complex for the general population, suggesting a need for more accessible assessment tools. Magnetic Resonance Imaging (MRI) has shown utility in diagnosing gynecomastia and differentiating it from other male breast pathologies (PMID: 40913704).

*   **Treatment and Management:**\n    *   **Prostate Cancer Patients:** Gynecomastia can be a side effect of hormone therapies used to treat prostate cancer, particularly androgen receptor pathway inhibitors (ARPIs). Management strategies include observation, pharmacotherapy (like tamoxifen), and radiotherapy. Studies suggest that tamoxifen can be effective in preventing or treating ARPI-induced gynecomastia (PMID: 40561872, 40404535, 39935942).
    *   **Adolescent Gynecomastia:** This condition, along with other breast deformities in adolescents, can cause significant psychosocial distress. A multidisciplinary team approach, involving plastic surgeons, is recommended for comprehensive care (PMID: 40406639).
    *   **Surgical Intervention:** While not explicitly detailed in all summaries, surgery is mentioned as a treatment option for gynecomastia (PMID: 40331995). The specific types of surgical procedures and their outcomes are areas of ongoing interest.

*   **Underlying Mechanisms and Related Conditions:** Research is exploring the mechanisms linking gynecomastia to male breast cancer, focusing on hormonal imbalances and genetic factors (PMID: 39909181). Dermatologic conditions of the breast can also manifest as gynecomastia (PMID: 40388094). Additionally, tremors have been associated with Klinefelter syndrome, a condition that can also involve gynecomastia (PMID: 40304653).

**Conclusion:**

Gynecomastia is a condition with multifaceted implications, ranging from physical appearance to psychosocial well-being. While diagnostic and treatment options are evolving, particularly in the context of prostate cancer therapy, further research is needed to develop comprehensive and accessible patient-reported outcomes and to fully understand the relationship between gynecomastia and other health conditions.

**PMIDs:** 41263895, 40913704, 40331995, 40561872, 40404535, 40406639, 40388094, 40304653, 39909181, 39935942.
-----------------------------------------------------------
Function calls:

-----------------------------------------------------------
Raw response:
{"sdk_http_response":{"headers":{"content-type":"application/json; charset=UTF-8","vary":"Origin, X-Origin, Referer","content-encoding":"gzip","date":"Mon, 01 Dec 2025 05:58:23 GMT","server":"scaffolding on HTTPServer2","x-xss-protection":"0","x-frame-options":"SAMEORIGIN","x-content-type-options":"nosniff","server-timing":"gfet4t7; dur=4531","alt-svc":"h3=\":443\"; ma=2592000,h3-29=\":443\"; ma=2592000","transfer-encoding":"chunked"}},"candidates":[{"content":{"parts":[{"text":"## Report: Understanding Gynecomastia Surgery\n\nThis report synthesizes findings from recent research on gynecomastia, a condition characterized by the enlargement of male breast tissue. The research highlights various aspects, including diagnostic tools, treatment strategies, and the impact of gynecomastia on patients' quality of life.\n\n**Key Findings:**\n\n*   **Diagnostic Challenges and Patient-Reported Outcomes:** A systematic review (PMID: 41263895) found that while existing patient-reported outcome measures (PROMs) capture some aspects of gynecomastia, there are significant gaps in assessing the full spectrum of quality of life impacts. Furthermore, the readability of many PROMs is too complex for the general population, suggesting a need for more accessible assessment tools. Magnetic Resonance Imaging (MRI) has shown utility in diagnosing gynecomastia and differentiating it from other male breast pathologies (PMID: 40913704).\n\n*   **Treatment and Management:**\\n    *   **Prostate Cancer Patients:** Gynecomastia can be a side effect of hormone therapies used to treat prostate cancer, particularly androgen receptor pathway inhibitors (ARPIs). Management strategies include observation, pharmacotherapy (like tamoxifen), and radiotherapy. Studies suggest that tamoxifen can be effective in preventing or treating ARPI-induced gynecomastia (PMID: 40561872, 40404535, 39935942).\n    *   **Adolescent Gynecomastia:** This condition, along with other breast deformities in adolescents, can cause significant psychosocial distress. A multidisciplinary team approach, involving plastic surgeons, is recommended for comprehensive care (PMID: 40406639).\n    *   **Surgical Intervention:** While not explicitly detailed in all summaries, surgery is mentioned as a treatment option for gynecomastia (PMID: 40331995). The specific types of surgical procedures and their outcomes are areas of ongoing interest.\n\n*   **Underlying Mechanisms and Related Conditions:** Research is exploring the mechanisms linking gynecomastia to male breast cancer, focusing on hormonal imbalances and genetic factors (PMID: 39909181). Dermatologic conditions of the breast can also manifest as gynecomastia (PMID: 40388094). Additionally, tremors have been associated with Klinefelter syndrome, a condition that can also involve gynecomastia (PMID: 40304653).\n\n**Conclusion:**\n\nGynecomastia is a condition with multifaceted implications, ranging from physical appearance to psychosocial well-being. While diagnostic and treatment options are evolving, particularly in the context of prostate cancer therapy, further research is needed to develop comprehensive and accessible patient-reported outcomes and to fully understand the relationship between gynecomastia and other health conditions.\n\n**PMIDs:** 41263895, 40913704, 40331995, 40561872, 40404535, 40406639, 40388094, 40304653, 39909181, 39935942."}],"role":"model"},"finish_reason":"STOP","index":0}],"model_version":"gemini-2.5-flash-lite","response_id":"fy4tacWyLYXO_uMP_dbxyQw","usage_metadata":{"candidates_token_count":704,"prompt_token_count":2784,"prompt_tokens_details":[{"modality":"TEXT","token_count":2784}],"total_token_count":3488}}
-----------------------------------------------------------

base_events.py:1833 ERROR:an error occurred during closing of asynchronous generator <async_generator object stdio_client at 0x112f99000>
asyncgen: <async_generator object stdio_client at 0x112f99000>
  + Exception Group Traceback (most recent call last):
  |   File "/opt/anaconda3/envs/mcp-agent/lib/python3.12/site-packages/anyio/_backends/_asyncio.py", line 781, in __aexit__
  |     raise BaseExceptionGroup(
  | BaseExceptionGroup: unhandled errors in a TaskGroup (1 sub-exception)
  +-+---------------- 1 ----------------
    | Traceback (most recent call last):
    |   File "/opt/anaconda3/envs/mcp-agent/lib/python3.12/site-packages/mcp/client/stdio/__init__.py", line 189, in stdio_client
    |     yield read_stream, write_stream
    | GeneratorExit
    +------------------------------------

During handling of the above exception, another exception occurred:

Traceback (most recent call last):
  File "/opt/anaconda3/envs/mcp-agent/lib/python3.12/site-packages/mcp/client/stdio/__init__.py", line 183, in stdio_client
    anyio.create_task_group() as tg,
    ^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/opt/anaconda3/envs/mcp-agent/lib/python3.12/site-packages/anyio/_backends/_asyncio.py", line 787, in __aexit__
    if self.cancel_scope.__exit__(type(exc), exc, exc.__traceback__):
       ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/opt/anaconda3/envs/mcp-agent/lib/python3.12/site-packages/anyio/_backends/_asyncio.py", line 459, in __exit__
    raise RuntimeError(
RuntimeError: Attempted to exit cancel scope in a different task than it was entered in
